Clinical improvement at week 12 (PHOENIX II)
\r\n\t
",isbn:"978-1-83968-236-0",printIsbn:"978-1-83968-235-3",pdfIsbn:"978-1-83968-237-7",doi:null,price:0,priceEur:0,priceUsd:0,slug:null,numberOfPages:0,isOpenForSubmission:!1,hash:"c85e82851e80b40282ff9be99ddf2046",bookSignature:"Dr. Rama Sashank Madhurapantula, Prof. Joseph Orgel P.R.O. and Ph.D. Zvi Loewy",publishedDate:null,coverURL:"https://cdn.intechopen.com/books/images_new/8018.jpg",keywords:"Collagen, Proteoglycans, Arthritis, Congenital Diseases, Osteogenesis Imperfecta, Blood Vessels, ECM - Tissue Interfaces, Elasticity, Cartilage Implant, Bone Graft, Angiogenesis, Extracellular Triggers",numberOfDownloads:18,numberOfWosCitations:0,numberOfCrossrefCitations:0,numberOfDimensionsCitations:0,numberOfTotalCitations:0,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"July 3rd 2020",dateEndSecondStepPublish:"July 24th 2020",dateEndThirdStepPublish:"September 22nd 2020",dateEndFourthStepPublish:"December 11th 2020",dateEndFifthStepPublish:"February 9th 2021",remainingDaysToSecondStep:"7 months",secondStepPassed:!0,currentStepOfPublishingProcess:5,editedByType:null,kuFlag:!1,biosketch:"Most recently, dr. Madhurapantula has been involved with developing microscopy techniques to establish macroscopic stress vs. strain relations in body tissues that present mixed tissue compositions, in conjunction with X-ray diffraction scanning techniques to establish tissue composition.",coeditorOneBiosketch:"Prof. Orgel is a multi-disciplinarian by research and professional practice with international name recognition in the collagen and connective tissue fields and in X-ray diffraction.",coeditorTwoBiosketch:null,coeditorThreeBiosketch:null,coeditorFourBiosketch:null,coeditorFiveBiosketch:null,editors:[{id:"212416",title:"Dr.",name:"Rama Sashank",middleName:null,surname:"Madhurapantula",slug:"rama-sashank-madhurapantula",fullName:"Rama Sashank Madhurapantula",profilePictureURL:"https://mts.intechopen.com/storage/users/212416/images/system/212416.jpg",biography:"Dr. Madhurapantula holds a Ph.D. in Biology from the Illinois Institute of Technology, Chicago, with a focus on the molecular structure and function of type I collagen. Since obtaining his Ph.D., he has worked on various ECM based research projects on understanding the structural aspects of various fibrous tissue assemblies in the human body, in non-disease and disease conditions. He is an expert in the field of in situ X-ray fiber diffraction. Most recently, he has been involved with developing microscopy techniques to establish macroscopic stress vs. strain relations in body tissues that present mixed tissue compositions, in conjunction with X-ray diffraction scanning techniques to establish tissue composition. These datasets together are being used to develop a high definition model of human heart valves with accurate stress-strain finite element models to improve the characteristics of these tissues in the CAVEMAN full human body simulation, which is further utilized in simulated blast and vehicular accident calculations, and to develop a simulated surgery apparatus to train surgeons.",institutionString:"Illinois Institute of Technology",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"1",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"Illinois Institute of Technology",institutionURL:null,country:{name:"United States of America"}}}],coeditorOne:{id:"212413",title:"Prof.",name:"Joseph",middleName:null,surname:"Orgel P.R.O.",slug:"joseph-orgel-p.r.o.",fullName:"Joseph Orgel P.R.O.",profilePictureURL:"https://mts.intechopen.com/storage/users/no_image.jpg",biography:null,institutionString:"Illinois Institute of Technology",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"1",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"Illinois Institute of Technology",institutionURL:null,country:{name:"United States of America"}}},coeditorTwo:{id:"235950",title:"Ph.D.",name:"Zvi",middleName:null,surname:"Loewy",slug:"zvi-loewy",fullName:"Zvi Loewy",profilePictureURL:"https://mts.intechopen.com/storage/users/235950/images/system/235950.png",biography:"Dr. Zvi Loewy, a senior academic leader and an experienced global pharmaceutical – biotechnology executive leverages a diversified background in big-pharma senior management, biotech startup creation and academia. \nDr. Loewy’s international experience has included leading international research teams; championing the commercial penetration of healthcare products in China; and leading open innovation in the Mid-East. \nDr. Loewy received his education at Rensselaer Polytechnic Institute and at the Albert Einstein College of Medicine. Dr. Loewy is on the faculty of the Touro College of Pharmacy and New York Medical College; is on the boards of the New Jersey Bioscience Incubator; and is an Editor of the Journal of Prosthodontics. Dr. Loewy has published broadly and has over 25 issued patents.",institutionString:"New York Medical College",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"0",totalChapterViews:"0",totalEditedBooks:"1",institution:{name:"New York Medical College",institutionURL:null,country:{name:"United States of America"}}},coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"6",title:"Biochemistry, Genetics and Molecular Biology",slug:"biochemistry-genetics-and-molecular-biology"}],chapters:[{id:"74538",title:"The Cellular Stress Response Interactome and Extracellular Matrix Cross-Talk during Fibrosis: A Stressed Extra-Matrix Affair",slug:"the-cellular-stress-response-interactome-and-extracellular-matrix-cross-talk-during-fibrosis-a-stres",totalDownloads:17,totalCrossrefCites:0,authors:[null]},{id:"74739",title:"The Evolutionary Origin of Elastin: Is Fibrillin the Lost Ancestor?",slug:"the-evolutionary-origin-of-elastin-is-fibrillin-the-lost-ancestor",totalDownloads:5,totalCrossrefCites:0,authors:[null]}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},personalPublishingAssistant:{id:"297737",firstName:"Mateo",lastName:"Pulko",middleName:null,title:"Mr.",imageUrl:"https://mts.intechopen.com/storage/users/297737/images/8492_n.png",email:"mateo.p@intechopen.com",biography:"As an Author Service Manager my responsibilities include monitoring and facilitating all publishing activities for authors and editors. From chapter submission and review, to approval and revision, copyediting and design, until final publication, I work closely with authors and editors to ensure a simple and easy publishing process. I maintain constant and effective communication with authors, editors and reviewers, which allows for a level of personal support that enables contributors to fully commit and concentrate on the chapters they are writing, editing, or reviewing. I assist authors in the preparation of their full chapter submissions and track important deadlines and ensure they are met. I help to coordinate internal processes such as linguistic review, and monitor the technical aspects of the process. As an ASM I am also involved in the acquisition of editors. Whether that be identifying an exceptional author and proposing an editorship collaboration, or contacting researchers who would like the opportunity to work with IntechOpen, I establish and help manage author and editor acquisition and contact."}},relatedBooks:[{type:"book",id:"6694",title:"New Trends in Ion Exchange Studies",subtitle:null,isOpenForSubmission:!1,hash:"3de8c8b090fd8faa7c11ec5b387c486a",slug:"new-trends-in-ion-exchange-studies",bookSignature:"Selcan Karakuş",coverURL:"https://cdn.intechopen.com/books/images_new/6694.jpg",editedByType:"Edited by",editors:[{id:"206110",title:"Dr.",name:"Selcan",surname:"Karakuş",slug:"selcan-karakus",fullName:"Selcan Karakuş"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1591",title:"Infrared Spectroscopy",subtitle:"Materials Science, Engineering and Technology",isOpenForSubmission:!1,hash:"99b4b7b71a8caeb693ed762b40b017f4",slug:"infrared-spectroscopy-materials-science-engineering-and-technology",bookSignature:"Theophile Theophanides",coverURL:"https://cdn.intechopen.com/books/images_new/1591.jpg",editedByType:"Edited by",editors:[{id:"37194",title:"Dr.",name:"Theophanides",surname:"Theophile",slug:"theophanides-theophile",fullName:"Theophanides Theophile"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3092",title:"Anopheles mosquitoes",subtitle:"New insights into malaria vectors",isOpenForSubmission:!1,hash:"c9e622485316d5e296288bf24d2b0d64",slug:"anopheles-mosquitoes-new-insights-into-malaria-vectors",bookSignature:"Sylvie Manguin",coverURL:"https://cdn.intechopen.com/books/images_new/3092.jpg",editedByType:"Edited by",editors:[{id:"50017",title:"Prof.",name:"Sylvie",surname:"Manguin",slug:"sylvie-manguin",fullName:"Sylvie Manguin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3161",title:"Frontiers in Guided Wave Optics and Optoelectronics",subtitle:null,isOpenForSubmission:!1,hash:"deb44e9c99f82bbce1083abea743146c",slug:"frontiers-in-guided-wave-optics-and-optoelectronics",bookSignature:"Bishnu Pal",coverURL:"https://cdn.intechopen.com/books/images_new/3161.jpg",editedByType:"Edited by",editors:[{id:"4782",title:"Prof.",name:"Bishnu",surname:"Pal",slug:"bishnu-pal",fullName:"Bishnu Pal"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"72",title:"Ionic Liquids",subtitle:"Theory, Properties, New Approaches",isOpenForSubmission:!1,hash:"d94ffa3cfa10505e3b1d676d46fcd3f5",slug:"ionic-liquids-theory-properties-new-approaches",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/72.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1373",title:"Ionic Liquids",subtitle:"Applications and Perspectives",isOpenForSubmission:!1,hash:"5e9ae5ae9167cde4b344e499a792c41c",slug:"ionic-liquids-applications-and-perspectives",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/1373.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"57",title:"Physics and Applications of Graphene",subtitle:"Experiments",isOpenForSubmission:!1,hash:"0e6622a71cf4f02f45bfdd5691e1189a",slug:"physics-and-applications-of-graphene-experiments",bookSignature:"Sergey Mikhailov",coverURL:"https://cdn.intechopen.com/books/images_new/57.jpg",editedByType:"Edited by",editors:[{id:"16042",title:"Dr.",name:"Sergey",surname:"Mikhailov",slug:"sergey-mikhailov",fullName:"Sergey Mikhailov"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"371",title:"Abiotic Stress in Plants",subtitle:"Mechanisms and Adaptations",isOpenForSubmission:!1,hash:"588466f487e307619849d72389178a74",slug:"abiotic-stress-in-plants-mechanisms-and-adaptations",bookSignature:"Arun Shanker and B. Venkateswarlu",coverURL:"https://cdn.intechopen.com/books/images_new/371.jpg",editedByType:"Edited by",editors:[{id:"58592",title:"Dr.",name:"Arun",surname:"Shanker",slug:"arun-shanker",fullName:"Arun Shanker"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"878",title:"Phytochemicals",subtitle:"A Global Perspective of Their Role in Nutrition and Health",isOpenForSubmission:!1,hash:"ec77671f63975ef2d16192897deb6835",slug:"phytochemicals-a-global-perspective-of-their-role-in-nutrition-and-health",bookSignature:"Venketeshwer Rao",coverURL:"https://cdn.intechopen.com/books/images_new/878.jpg",editedByType:"Edited by",editors:[{id:"82663",title:"Dr.",name:"Venketeshwer",surname:"Rao",slug:"venketeshwer-rao",fullName:"Venketeshwer Rao"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"4816",title:"Face Recognition",subtitle:null,isOpenForSubmission:!1,hash:"146063b5359146b7718ea86bad47c8eb",slug:"face_recognition",bookSignature:"Kresimir Delac and Mislav Grgic",coverURL:"https://cdn.intechopen.com/books/images_new/4816.jpg",editedByType:"Edited by",editors:[{id:"528",title:"Dr.",name:"Kresimir",surname:"Delac",slug:"kresimir-delac",fullName:"Kresimir Delac"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},chapter:{item:{type:"chapter",id:"44175",title:"Psoriasis as a Chess Board — An Update of Psoriasis Pathophysiology",doi:"10.5772/53580",slug:"psoriasis-as-a-chess-board-an-update-of-psoriasis-pathophysiology",body:'By virtue of the dynamic nature of the scientific process, the description of the pathogenesis of a disease is always a work in progress. Each day new research shapes and refines our understanding of disease processes; an attempt to describe the current scientific understanding provides merely a snapshot of a body of knowledge that is constantly changing. However, characterizing a disease using homeostatic and physiological terms allows the creation of a framework to convey the most up-to-date theories while maintaining the potential for their evolution.
The complex nature of psoriasis can similarly be unveiled through understanding the historical context of our current understanding, examining prevailing hypotheses, and extrapolating horizons for new research. To develop a framework for understanding the pathogenesis of psoriasis and its evolution, the first perception to be changed is the prevalent view of the immune system. The general notion of the immune system as a defense arrangement that protects us against the microorganisms must be changed. This view results from a reduction of the process itself and, as mentioned by Dr. Nelson Vaz, are features derived from the birth of the immunology [1]. Immunology, as a scientific field, is new in the history of medicine. Immunology developed in a century marked by the First and Second World War and Cold War tension. Hence, many models to exemplify the immunological concepts were simplified and described in relation to war affairs to facilitate the understanding of this science. In this model, if a microorganism attacks a human being, the individual advocates the use of the immune system to counteract. Another simple aspect is the teleology that prevails in the immune science. For example, the T lymphocyte exists to kill cells infected with intracellular parasites. This model full of logic and consequences does not apply in many other areas of medical and non-medical sciences. As such, it is necessary to move to a new approach to describing the relationship between the immune system and environment. In this new paradigm, the immune system does not react, but rather interacts with the environment, and this contact is made through the skin and mucous membranes. This interaction, causal or not, can have different results. In most cases, there is a balance, imperceptible to other sensory systems, which is characterized by the integrity of what we call health. Thus, homeostasis disorders or imbalances lead to disease. This seems obvious when written, but this search for stability has continuity for the duration of the life of a given organism. If we consider the immune system a sensorial system, it interacts with the modifications of the environment, detects this information of change, and responds with adjustments to maintain homeostasis. You might reduce this view by comparing it to an engine that runs under different types of fuel mixture. It detects the different fuel composition and changes the compression ratio of the cylinder for better efficiency to keep the car moving.
For better observation of this psoriasis pathogenesis, we will make a technical simulation of the immune system in a specific situation. This simulation will cover various aspects of immune response, spanning from the beginning of the inflammatory response, to specific immune response through the development of psoriasis. Here, under a historical perspective and comparing with a chess game, the main objective is to provide insights on the central role of some of these cytokines and immunological pathways in psoriasis pathophysiology. Through this, the aim is to explain some facts of modern immunodermatology that might be useful for clinicians to understand the basis of the immunology of psoriasis. Moreover, an important goal is to dispel some misinformation that might have a negative impact on the use of new immunomodulators and medications available for use by physicians. Treatment basis and therapeutic response experience strongly supports the use of immunomodulators as important modalities in the treatment of psoriatic arthritis and plaque psoriasis. Studies with these therapeutic agents, which act in different steps of the psoriatic inflammatory cascade, have also shown significant efficacy. [2].
Directly targeting this inflammatory cascade, blocking specific cytokines is a modern treatment option for psoriasis and other autoimmune diseases [3]. The rationale for this therapy arises from pathophysiology; in different autoimmune diseases there is an increase in production of proinflammatory cytokines by the immune system. Inflammatory cytokines, like many other cytokines, have an important role in both maintaining health and participating in disease manifestation [4]. This chapter discusses the pivotal role of some of these cytokines in psoriasis pathophysiology, how our understanding of its mechanism evolved, and how blocking the effect of a specific cytokine might substantially improve the disease condition.
Psoriasis is a common skin disease with extra-cutaneous manifestations. It is characterized by chronic inflammation of the skin with changes in the maturation of keratinocytes, which is manifested by the hyperproliferation of the epidermis. Moreover, inflammatory reaction can be found in other systems of the same patient. However, this disease is mediated by T lymphocytes, orchestrated by orchestration multigenic and environmental factors. The altered immune system is essential for the inflammation present in both the skin and other organs. A concept of a multi-systemic disorder involving different organs of the patient and reflects a better understanding of the complex pathophysiology of this disease [2].
The concept of biological therapy for psoriasis has been derived from its etiopathogenesis. As in a chess game, these new forms of treatment have evolved from an integration of the knowledge of interactions between the immune system cells (pieces) and its cytokines (movements) that initiates the pathologic processes and ultimately leads to the development of the clinical features of psoriasis.
In ancient records, the initial causes of psoriasis were attributed to multiple sources ranging from the divine power to racial associations [5]. An unknown infectious organism was indicated as a source of psoriasis in 1927 [6]. Later, its etiology was described as primarily and essentially an epidermal problem, independent of immunologic phenomena [7]. The main objective of cytotoxic drugs developed in the 20th century, such as methotrexate, was to reduce keratinocyte proliferation. Immunological studies on psoriatic patients identified changes in humoral immune reactions as part of the overall problem but not the cause [8, 9]. Efficacy of the cytotoxic drugs in the late 1960s paved the road for ideas about the role of the immune system in psoriasis [10, 11]. Further investigations in the 1970s revealed the role of immunologic factors in psoriasis. However, the dominant thought was that psoriasis was a disease of faulty epidermopoiesis due to impaired autocontrol mechanisms [12]. Hunter et al. wrote “More work on cell turnover and its regulation will give the clue to psoriasis” [13].
Other studies in the 1970s revealed the role of immunologic factors in psoriasis. Histopathologic examination of psoriatic lesions showed a striking resemblance to cellular inflammatory reactions observed in allergic contact dermatitis [14]. A selective immunosuppressant effect was the initial hypothesis used to describe the pathological cellular immune response [15]. Soon thereafter, the discovery of a soluble factor that played an important role in keratinocyte proliferation helped to form the cytokine-based theory for the induction/maintenance of the inflammatory and proliferative cascades of psoriatic lesions [16]. Subsequently, an integrated theory explaining the etiopathogenesis of psoriasis came into play: in a genetically susceptible patient, immunological factors trigger rapid turnover in the epidermis resulting in the development of psoriasis [17].
The fundamental confirmation that any defect of the skin is not sufficient by itself to maintain a psoriatic lesion occurred in the subsequent decade. Some studies confirmed that T cells and soluble factors could stimulate keratinocyte proliferation. Immunophenotyping of psoriatic lesions showed mixed T lymphocyte (TL) cell populations (CD4 and CD8) and Langerhans cells (LCs) distinct from normal skin [18]. This cellular infiltrate changed with topical or systemic treatment [19, 20]. In another study, failure of plasma exchange and leukapheresis ruled out the major participation of humoral immune system in the pathogenesis of psoriasis [21]. Thus, the cellular arm of the immune system was implicated in psoriasis for the first time during the 1980s [22].
During the 1990s, research on immunopathogenesis of psoriasis thus focused on the cellular and the cytokine components of the immune system. Researchers observed that an influx of activated T lymphocytes, mainly CD4+, HLA-DR+, Interleukin (IL)-2 receptor - CD25+ T cells, was one of the earliest events of psoriasis [23]. Based on Mosmman and Coffman’s publication [24], these T lymphocytes were classified as T helper (Th) type 1 cytokine producers (Th1) [25]. They produce Interferon (IFN)-γ, IL-2, and Tumor Necrosis Factor (TNF)-α cytokines and implied that a cellular type 1 reaction was responsible for psoriasis (Figure 1). The observation of the historical evolution of the extra-cutaneous manifestations of psoriasis and their pathogenesis confirms the idea of a multi-organ disease with complex immunological pathways [2].
Time line of development of psoriasis pathophysiology: From unknown to epidermal problem through Immunological disease.
Psoriasis plaque is induced and maintained by multiple interactions between cells of the skin and immune system. It seems that the pathogenesis of psoriasis could involve a stage of cellular infiltration resulting in epidermal (keratinocyte) proliferation. Each inflammatory pathway (IL-12/Th1, IL-23/Th17, and IL-22/Th22) has its impact on psoriasis development [26]. The different pathways are based on the fact that T helper cells can be skewed towards mutually exclusive subtypes on the basis of the cytokine environment [27, 28]. The process of T lymphocyte reactivation results from interaction of T cells with the resident antigen presenting cells (APCs) found in plaque psoriasis, which in turn determines the cytokine environment and Th1/Th17/Th22 pathway.
The primary etiopathogenesis of an autoimmune disease, or the activation of Th1/Th17/Th22 pathways, is the dysregulation of immune system activation since the development of autoreactive lymphocytes occurs in the same basic manner as lymphocyte activation. The understanding of this process or processes is very important to maintain the balance of the normal performance of the immune system. Briefly, it is comparable to the process to find the moment where one player lost the chess game based on the retroactive analysis of his moves. Cytokines are the possible moves of different pieces of the game. Many pieces can produce the same movement but with different results. The moves are the key players in generating or establishing a specific immune system reaction. Therefore, blocking cytokines that maintain autoimmune activity has become one the most successful strategies for autoimmunity therapy. A new balance can be established with the removal of a key piece or blocking of a lethal move so that the critical players are removed from the chessboard of an autoimmune response.
As with any other disease involving the immune system, psoriatic manifestation begins with Antigen-Presenting Cells (APC) activation by an unknown trigger. Different factors including infections, trauma, medications, and emotional stress can initiate the initial phase of the disease. Such factors can activate keratinocytes to release cytokines such as IL-1 and TNF-α, initiating the effector phase of psoriasis by activating resident skin macrophages and Dendritic Cells (DCs). DCs migrate to the regional lymph node, which initiates T lymphocyte activation in response to the stimuli. This is part of the working model of the immune synapse of T cells in psoriasis, integrating T cell signaling pathways in autoimmunity [29]. This association leads to the production of IL-12/Th1/IFN-γ pathway. Many molecules in the plasma membrane of both cells, other than the Major Histocompatibility Complex (MHC) and T Cell Receptor (TCR), are involved in this phase and can be used as a target molecule for the treatment of psoriasis. The most important molecules are ICAM-1, LFA-3, and CD80/CD86 in the DC and LFA-1, CD2, and CD28 in the T cell, respectively. Alefacept, a fusion protein used for psoriasis treatment, blocks T cells activation by interfering with CD2 on the T cell membrane, thereby blocking the costimulatory molecule LFA-3/CD2 interaction [30]. Furthermore, it has recently been discovered that IL-27 suppressed macrophage responses to TNF-α and IL-1β, thus identifying an anti-inflammatory function of IL-27 [31].
Continuing the evolving complex immunological chess game, the activated T lymphocyte Th1 cytokine producers leave the lymph node and migrate to the skin where cytokines like TNF-α, produced by keratinocytes and activated DCs, facilitate T lymphocyte diapedesis into the dermis and epidermis [32]. The TNF-α induces the skin immune cell infiltration by inducing chemokines and upregulating adhesion molecules on the endothelial cells of dermal vessels. Adhesion molecules such as CLA and LFA-1 on the T lymphocyte membrane and E-selectin and ICAM-1 on the endothelial cell membrane are involved in this process. Efalizumab, a Humanized Anti-CD11a, Anti-LFA-1 molecule has been used in psoriasis treatment by blocking the TL migration to the skin [33]. In summary, dendritic cells and effector T-cells are important in the development of the psoriatic lesion, and cytokines produced by these cells stimulate keratinocytes to proliferate and increase the migration of inflammatory cells into the skin, promoting epidermal hyperplasia and inflammation [34].
The primary cause of psoriasis has not been not found. Factors such as genetics and environmental exposure are now recognized to play a role in psoriasis development. Certainly, autoimmunity does not appear to be the only, or necessary, component to the development of psoriasis. However, psoriasis is a manifestation of skin immune reactions. Inflammation is a key feature of pathogenesis, with all inflammatory cell types implicated in psoriasis pathology by multiple interactions between cells of the skin or from other organs and the immune system. Nonetheless, the etiology of psoriasis as an epidermal problem or a disease of faulty epidermopoiesis due to impaired autocontrol mechanisms is not completely wrong. Keratinocyte-derived inflammatory molecules ampliy skin immune responses associated with psoriasis, and contribute to the disease process and clinical phenotype [35]. Psoriatic keratinocytes respond aberrantly to cytokines and show altered intracellular signaling pathways [36].
Heterogeneous functions of other skin resident cells, such as fibroblasts and endothelial cells, may also contribute to the pathogenesis of psoriasis [37]. Furthermore, leukocytes that infiltrate skin lesions have been shown to be involved in the pathogenesis of this disease [38]. Despite parallels to the chicken and egg causality dilemma, all of these contribute to the presentation in patients suffering from psoriasis that is later observed by clinicians.
From the previous data, it is well known that the immunopathogenesis of psoriasis is complex. It involves alterations in the innate and acquired immunologic system. In the most accepted models, cells of the skin when activated produce immunological mediators that act upon the cells of the specific immune system. The action is amplified by the opposite direction [39].
The most studied theories about autoimmune disease etiology associate the immune dysregulation and loss of tolerance due to the impact of environmental factors on genetically susceptible individuals. The literature has always highlighted the importance of the microorganism in the lack of immune homeostasis in psoriasis. The linkage of antigens of infectious agents to the toll like receptors can activate keratinocytes and other cells to release innumerous chemokines, cytokines and growth factors. Activated keratinocytes are capable of recruiting and activating T cells. Therefore, infections are considered an important component that can unleash the manifestation of psoriasis[40].
In accordance to the actual immunopathogenesis models for psoriasis, the skin is the body’s primary defense against external invasion. However, the keratinocytes, in defending the body against the microorganism, induces the migration of cutaneous lymphocyte-associated antigen (CLA) positive T cells. Finally, T cells play a central role in initiating and perpetuating the immunological mechanisms of psoriasis [41].
In this context, the possibility arises that endogenous, normal, housekeeping self-proteins might be epitopic targets in autoimmune responses in psoriasis. The transition from self-reactivity to the autoimmune pathology appears to be mediated by a complex network of overlapping phenomena [42]. However, all studies about the antigen identification in psoriasis, like in many other autoimmune diseases, did not find an optimal autoantigen for studying the relationship between similarity level and immune responses [43].
Therefore, the actual models of immunopathogenesis of psoriasis break the specificity basic statement of immunology. There are historical reasons for the dissociation between immunopathogenesis models and immunology concepts. Immunology emerged as a biomedical science, concerned with host defense and production of anti-infectious vaccines. Ehrlich’s side-chain theory explained the anti-infectious protection granted by vaccines and serotherapy [44]. It was the first steps of the development of initial cognitive metaphors, such as recognition and memory.
The clonal selective theory of antibody formation in the 1950s was a new evolution and the initiation of neo-Darwinism in Immunology. The selective theories of antibody formation resulted from the union of Immunology with Darwin’s theory of evolution. They also amplified the “Defensive metaphors". Lymphocytes are supposed to respond specifically to stimuli. Except for brief moments of activating or inhibiting interactions, lymphocytes are believed to act independently from each other. Therefore, the immune system defends the body by amplification of specific lymphocytes.
In seeking to understand the unknown, mysterious, or abstract, the human mind draws comparisons to the known, familiar, and concrete. When these comparisons are made explicit, we call them metaphors or analogies. Scientists draw on metaphors when struggling with phenomena that defy easy observation, such as the immune system. Immunology developed many metaphors based on the scenario of its development. The naissance of immunology was marked by the great World Wars and the Cold War tension. Consequently, immunological concepts were simplified and described as war affairs.
The war metaphor for the immune response is appealing, in part, because it seems to create a deeper understanding of the rules that direct the immune system actions. The consequence of immunologists’ fondness for war metaphors, the authentication of the models has hardly been tapped. However, any metaphors used to explain the immune system evoke intuitive notions of strategy, skill and competition. Rarely do they indicate a deep understanding of the particular clinical variation present in the arenas of medical life.
The underlying principle in this framework is the immune system as a "defense system.” When it is said that the immune system defends the body, there is the use, intentionally or not, of a metaphor. This is also a teleological argument (from the Greek τέλος for "end", "purpose", or "goal"). Teleological argument is a knowledge or explanation about a fact that relates to a final question. Teleological reasoning is an anthropomorphic interpretation used in science. Therefore, it is given that there is an end or a function for the biological being or immune system. However, there is not much teleological argument in physics or other natural science fields. Do you know any reason why the earth gravitates around the sun?
Immunologists are in a comparable position to use metaphors inasmuch as the cellular and molecular relationships that form the immune response are things that cannot readily be seen. Famous and basilar modern immunological metaphors include viewing the immune system as a planning body at a multidimensional space in which the lymphocytes are developing defensive strategies against invaders or irritants. Another side of this favorite metaphor is that of the main reason why bacteria invade the bodies is because those bodies harbor environments where the bacteria can survive and multiply. The immune system protects the body from invaders like bacteria, viruses and parasites.
There are consequences to this metaphor interpretation. The immune system does not act as one structure or system. A system is described as a collection of elements connected to each other in such a way that acting upon one element has repercussions upon all the others. Lymphocytes are supposed to respond independently specifically to antigen stimuli. Therefore, lymphocytes do not interact with the organism or with other lymphocytes. They are clonal units. Thus, lymphocytes cannot organize themselves in a system.
In the actual stage of the clonal selection theory acceptance and consequent metaphor interpretation, the proposition of significantly different concepts or description of the immune system have been excluded from the scientific media. The net result of such a theoretic narrowness is the characterization of a massive variety of cellular or molecular independent components involved in immunological activity. Therefore, the expansion, contraction and regulation of specific clones of lymphocytes are insufficient to generate all known immunological phenomena. Finally, the lack of a different view about the immune system followed in a flagrant inability to create new vaccines, to understand and treat allergies or autoimmune diseases as psoriasis.
Does the interpretation of the data in immunology, as it is today, represent the only possible way to have an immune response? Is there a new model where the immune system can be explained and the immunopathogenesis of autoimmune diseases as psoriasis can be interpreted? This is a logical question that should follow the previous assumptions.
Consistent with the position that the details of a immune response matter, any other proposition begins by reviewing and incorporating the accepted rules, constraints, and properties available for the immune system - the Immunology game’s inner logic. The application of game theory to Immunology thinking is our new proposition to explain autoimmune diseases and other immunologic responses. The objective here is to begin taking games seriously as potential sources of insight into the relationship that determines the Immune system.
Game theory is a set of concepts aimed at decision making in situations of competition and conflict, as well as of cooperation and interdependence, under specified rules [45]. Game theory metaphors began with the idea regarding the existence of mixed-strategy towards equilibrium. The discordant note of this view of game theory with the actual immunological response is the prevailing opinion among game theorists that any interaction will eventually converge to Nash equilibrium predictions under the right conditions. Although the initial application of game theory to immunology does not involve any of the requirements of the Nash equilibrium, the human homeostasis conforms nicely to predictions of the Nash equilibrium or relevant refinement. Absence of homeostasis or disease is the lack of stability in the immune system concept.
Researchers are starting to realize that this simplistic view of the immune system as defensive system needs a radical rethink [46]. The focus has been less on equilibria that correspond to a notion of rationality or teleologism, but rather on ones that would be maintained by evolutionary forces. In this new view, the skin has no longer been thought of as a mere physical barrier to attack by pathogens. Recent studies suggest the interplay between the skin\'s resident microorganisms, known collectively as the skin microbiome, and immune mediated organ-specific diseases [47]. Increasingly, it has been recognized that disruptions in the commensal microflora may lead to immune dysfunction and autoimmunity. Therefore, the microbiome influence the host\'s immune system [48]. In particular, there are new findings on the role of the microbiome in psoriasis [49].
Biologists have used game theory. The known game theory equilibrium in biology is the evolutionarily stable strategy (ESS) [50]. Additionally, biologists have used evolutionary game theory and the ESS to explain many seemingly incongruous phenomena in nature. Paradoxically, it has turned out that game theory is more applied to biology than to the field of immunology for which it can be an evolutionary metaphor. Considering some of the ways in which game metaphors have been used in biology analysis, observing that most game metaphors involve only vague and fleeting references to some generic game with the goal of making a preconceived point. We contrast this with analogies in the natural sciences, in which knowledge of a well-understood phenomenon is used to shed light on another that is less well understood. A new idea has to propose a nonteleological view including all possible natural evolutions, which will necessarily generate other set of problems and enigmas. A nonteleological thinking is a way of viewing things as they are, rather than seeking explanations for them [51]. However, the practicality of a nonteleological view in immunology is null nowadays [45].
In summary, although the costs of infections to immune system are meaningful, a growing body of evidence supports a general benefit associated with infectivity. Reducing the risk of uncontrolled inflammation and limiting the tissue damage caused by injury are important features of host defense against pathogens, but would be beneficial in a variety of autoimmune diseases [52]. Game theory may help to appreciate the benefits of immunity to infection. This is the challenge for the new homeostatic immune system metaphors that explain the autoimmunity mechanisms as in psoriasis.
Psoriasis was defined as Th1 type of disease based on the early understanding of the T helper subsets. The initial belief was that infiltrating T cell subpopulations derived from the draining lymph node regulated the development of the inflammatory responses in the skin by producing IFN-γ and TNF-α [53]. The Th1-derived cytokines produced by these infiltrating Th1 favors further Th1 cell access, upregulates keratinocyte chemokine production, and supports dermal DC myeloid type (DC11c+) activation. In response to this cytokine activation, keratinocytes and other cells produce a plethora of immune mediators, which induce and amplify inflammatory responses in the skin [54].
As a result, two logical biologic therapeutic approaches were tested: one was the administration of counter regulatory type 2 cytokines and the second was the blocking of type 1 cytokines. The use of monoclonal antibodies or fusion proteins to neutralize cytokines started to be used on a large scale because of their efficacy and practicality.
These studies have proved to be a useful biological model and test ground for evaluation of the skin immune system and psoriasis. Although these drugs were not initially developed in the treatment of psoriasis, but rather in rheumatoid arthritis and Crohn’s disease, the observation that Crohn’s disease patients with psoriasis were improving while on anti-TNF therapy profoundly influenced the studies that were to come [55].
Although clinical response to anti-TNF suggested a role for Th1 cells in psoriasis, evidence coming from other studies demonstrated that Th1/Th2 paradigm and key role of TNF were not sufficient to explain the full pathogenesis of psoriasis. At this point some academic resistance to an immunological pathogenesis for psoriasis was raised [56]. However, the main interpretation was that an important piece of the immunological cytokine puzzle was missing. Many other pieces would be involved in such a complex game.
The initial quest for the missing cytokines was the search for pathway inducers. Researchers first noted that IL-12 is crucial for Th1-cell differentiation [57]. IL-12 signaling via its receptor activates Stat4 (signal transducer and activator of transcription 4), which upregulates IFN-γ. IFN-γ activates Stat1, which enhance T-bet (T-box expressed in T cells), the leading TH1 transcription factor, further enhancing IFN- γ production and downregulating IL-4 and IL-5 expression [58]. IFN-γ mediates many of the pro-inflammatory activities of IL-12. Phagocytes and Dendritic Cells (DCs) are the main producers of IL-12 in response to microbial stimulation [59], and this relationship links innate resistance and adaptive immunity. The main function of IL-12 is resistance to infections with bacteria and intracellular parasites. However, it plays an important role in the Th1 response that sustains organ-specific autoimmunity [60]. The use of anti-IL-12 mAb (monoclonal antibody) in an experimental model of psoriasis also suggested the therapeutic value of blocking IL-12 in humans [61], although side effects of the drug limited further development in this area.
For many years, the IL-12-dependent Th1 cells were thought to be essential for the induction of autoimmunity. However, during the Th1/Th2 paradigm studies, an IFN-γ-independent mechanism responsible for the pathogenesis of many inflammatory diseases and psoriasis was found [62]. IL-12 and IL-23, as discovered previously from human DNA sequence information, share the subunit p40 [63]. The use of anti-IL-12/23p40 and anti-IFN mAb ultimately established at least part of the solution to the riddle. Only neutralization of p40, but not of IFN-γ, ameliorated chronic inflammatory reactions. This finding suggested that the latter cytokine, IL-23, accounted for the IFN-γ-independent mechanism of inflammation.
Identified from human DNA sequence information, IL-23, like IL-12, is also a heterodimeric cytokine composed of the same subunit p40 paired with the unique p19 [64]. It has been reported that IL-12 and IL-23 are up-regulated in psoriatic skin [65]. Human studies with anti-IL-12p40 have shown that this treatment not only ameliorates psoriasis, but also down-regulates type 1 cytokines and IL-12/IL-23 in lesional skin [66]. Besides sharing the subunit p40 and signaling through similar receptors, IL-23 and IL-12 are responsible for driving different T-cell subsets. Moreover, presence of abundant IL-23+ dendritic cells as well as elevated mRNA expression for both subunits of IL-23 (IL-23p19 and IL-23p40) in psoriatic lesions supports the role of IL-23 in the pathogenesis of psoriasis [65, 67-69]. Genetic studies have revealed that polymorphisms in IL-23p19, IL-12/23p40, and IL-23R are associated with increased risk of psoriasis [70-72]. Furthermore, in an animal xenograft model of psoriasis, Tonel G et al showed that treatment with anti human IL-23 mAb causes statistically significant reduction of acanthosis and papillomatosis index in grafts of mice in comparison to isotype controlled mice. Moreover, they found comparable efficacy of anti human IL-23 mAb with anti TNF-α (infliximab) in blocking the development of psoriasis. They also showed a significant decrease in CD3+ T cells mainly in the epidermis of mice treated with anti human IL-23 mAb in comparison to control mice [73].
IL-23 could also mediate and sustain late-stage chronic inflammation by the production of IL-17 by Th17 [74]. IL-23 plays an important role as a central growth factor [75-77]. In presence of TGF-β and IL-6, IL-23 helps in development of Th17 cells whereas TGF-β is inhibitory to production of IL-22 [78-80] (Figure 2).
The pivotal role of some of IL-12 and IL-23 in psoriasis etiopathogenesis: How blocking the effects of these cytokines substantially improve the disease condition.
The IL-23/Th17/IL-17 immune axis was initially elucidated when IL-17 gene expression was induced by B. burgdorferi independent of IL-12 [81]. The IL-17–producing CD4+ T cells distinct from those producing either IL-4 or IFN-γ were called Th17 [82]. Patients with psoriasis have increased Th17 cells as well as increased expression of mRNA for Th17 cytokines (IL-17A; IL-17F; TNF-α; IL-21 and IL-22) and chemokines (CCL20) [83-87]. In psoriasis, Th17 cytokine IL-17A mainly induces cytokine and chemokine production by keratinocytes [84, 88, 89], whereas IL-22 induces proliferation of keratinocytes and production of antimicrobial peptides by keratinocytes [78, 90-92]. The role of IL-23 and IL-17 in psoriasis was further substantiated in some animal studies with recombinant IL-23 and anti IL-17A. In wild type (WT) mice, injection of recombinant murine (rm) IL-23 induces epidermal hyperplasia [93, 94], whereas, in IL-17 -/- mice showed less epidermal hyperplasia after repeated injection of rmIL-23. A recent publication by Rizzo et al showed that WT mice do not show epidermal hyperplasia to injection of rmIL-23 if they were treated with anti IL-17A antibodies [95]. A redundant cytokine model has emerged as the evolving explanation for psoriasis pathogenesis. It is based on the IL-12/Th1/ IFN-γ - TNF-α and the IL-23/Th17/IL-17 immune pathways (Figure 3). The effectiveness of the anti-TNF treatment of psoriasis validated the first axis. The efficacy of anti-p40 (anti-IL12/23) treatment confirms the other [96].
Time line of development of psoriasis pathophysiology: From complex immunological disease through genetic participation until recent advances.
IL-23 favors the proliferation of the Th17 subtype and consequent production of IL-22 and IL-6 that stimulates the proliferation of keratinocytes. IL-17 favors infiltration of neutrophils into the skin forming the typical Munro’s micro-abscesses with some participation of IL-22 [97].
Studies have demonstrated that anti-p40 (anti-IL-12/23) treatment is highly efficacious for psoriasis. Ustekinumab anti IL-12/23 antibody showed its efficacy and safety in three phase III trials recruiting 2899 patients. From two placebo controlled trials, PHOENIX 1 and PHOENIX 2, ustekinumab showed its efficacy in ameliorating psoriatic plaques, pruritus, and nail psoriasis [98]. (Table 1).
\n\t\t\t\t | \n\t\t
Clinical improvement at week 12 (PHOENIX II)
* P <0.001 Adapted from: Papp KA, Langley RG, Lebwohl M, et al. Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomized, double-blind, placebo-controlled trial (PHOENIX 2). Lancet. 2008; 371(9625):1675-1684.
Remarkably, in a phase II multicenter, randomized, double-blind, placebo-controlled trial briakinumab, another human monoclonal anti-IL-12/23 antibody, 90-93% of subjects in 4 dosing groups were able to achieve a PASI 75 [99]. This finding alone confirms the centrality of this pathway because these levels of efficacy have not been previously seen in studies with other agents [100]. Safety data for both agents is limited, but to date has been favorable.
One issue with anti-p40 therapy is that it inhibits both the classical IL-12/Th1/IFN-γ and IL-23/Th17/IL-17 immune pathways. IL-12 and IL-23 are related cytokines with differences in their biological activities. After binding to their receptors, different intracellular transcription complexes are activated [101]. IL-12 predominantly acts on naïve T cells and initiates the TH1 response. In contrast, IL-23 primarily affects memory T cells and expands the initiated Th1 inflammatory response by Th17 activity and maintains an adequate memory pool by compromising memory T cells [64, 101, 102]. Experimental studies suggest that IL-23/Th17/IL-17 immune axis blocking is sufficient to treat autoimmune inflammation [63].
Another way to block both pathways is the immunoregulatory role of IFN-γ. It is well-known that the administration of anti-IFN-γ induces exacerbation of Experimental Autoimmune Encephalomyelitis (EAE) [103]. One possible explanation is the inhibition of IL-12/Th1/IFN-γ axis may destroy the regulatory role of IFN-γ during chronic inflammation. TNF-α, like INF-γ, has a regulatory role in the immune system [104]. This might explain the observation that anti-TNF therapies can induce psoriasis and other autoimmune diseases in some patients [105].
An increase in efficacy and reduction of adverse events are the main drivers for new therapies. Infections, one type of adverse event, usually increase in patients receiving anti-cytokine therapy [106]. Studies with anti-IL-23 therapy will require surveillance for the development of opportunistic infections. Reports from patients with IL-12 and/or IL-23 cytokine deficiency syndromes alert to these potential infections in individuals under anti-IL-23 therapy. Invasive salmonellosis and mycobacterial diseases were present more often in patients with IL-12/IL-23 deficiency indicating that immunity against these microorganisms appears to be dependent of IL-12 and/or IL-23 [107]. However, antibodies against IL-12 and IL-23 may not cause a complete inactivity of these cytokines in a clinical scenario. For example, an experimental study showed that IL-23 plays a role in host defense against P. carinii, but it is not an essential one [108]. Clinical studies with anti-IL-12/23 treatment thus far have not increased the risk of non opportunistic or opportunistic infections [109]. A recent study showed that blocking IL-23 with monoclonal antibodies during BCG infection does not appear to affect the bacterial burden in immunocompetent mice. In contrast, blocking TNF-α or both IL-23 and IL-12 with anti-p40 dramatically enhances mycobacterial growth. From this study, antibody blockade of IL-23 alone rather than IL-12 might be preferable in patients who have been, or may be, exposed to mycobacterial infection [110].
As previously mentioned, the IL-23 favors the proliferation of the Th17 and consequent production of IL-22. IL-22 mRNA presence was initially described in IL-9 stimulated T-cell lines and in concanavalin A (Con-A)-activated murine spleen cells [111]. Further studies demonstrated that IL-22 expression can only be observed in activated immunological cells [112]. However, other reports have revealed that some T cells express IL-22 independently of IL-17 [113]. Finally, a new distinct human memory CD4+ T cell subset with skin-homing properties was identified and denominated Th22 [114].
A preferential production of IL-22 cytokine by T cells (Th22, Th17, and Th1) is present in psoriasis lesions [86]. Many animal models indicate the role of IL-22 in psoriasis. IL-22 over-expressed transgenic mice developed psoriasis-like skin lesions [115]. In IL-22 -/- mice, injection of IL-23 fails to induce epidermal hyperplasia indicating the role of IL-22 as a downstream mediator of tissue effects caused by IL-23 [78]. In a recent publication, Rizzo HL et al showed that to have IL-23 mediated epidermal hyperplasia, both IL-17 and IL-22 is required; any one of these is not sufficient to execute the effect of IL-23. They also showed that pre-treatment with anti IL-22 or anti IL-17A Abs block the rmIL-23 mediated epidermal hyperplasia in wild type mice [95]. In reconstituted epidermis model, IL-22 produces acanthosis dose dependently, which resembles psoriasis and either one of these alone is not sufficient to execute the effect of IL-23. The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis [92]. In a study by Wolk K et al, a correlation was demonstrated between the plasma IL-22 levels and the severity of the disease [90]. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes and may play a: a potential role in psoriasis [90]. Moreover, IL-22 levels correlated with IL-20 levels, which is in accordance with the IL-22-induced keratinocyte IL-20 production [116]. This suggests that IL-22 and its downstream mediator IL-20 play an important role in the final steps of psoriasis pathogenesis. Sabat R and his group in their studies showed that IL-22 regulates keratinocyte function in several ways: a. IL-22 helps form a biological barrier of the skin by producing antimicrobial proteins (AMPs) like β-defensins, and S100 proteins. This may be one of the reasons that psoriatic patients have less skin infections. b. IL-22 interferes with physiological desquamation process of skin by inhibiting the terminal differentiation of keratinocytes. c. IL-22 plays a role in recruiting neutrophilic granulocytes in skin by inducing the production of chemokines;. d. IL-22 indirectly helps in extracellular tissue degradation by inducing production of matrix metalloproteinases 1 and 3. IL-22 induces the production of IL-20, another IL-10 family cytokine which has similar effects as IL-22, thus resulting in amplification of the effects of IL-22 [117]. In a transgenic mouse model, it has been showed that IL-22 causes acanthosis, hyperkeratosis, and hypogranulosis, which are hallmarks of psoriasis. IL-22 acts through STAT-3 to impact the differentiation of keratinocytes [115]. IL-22 induces pro-inflammatory chemokines and antimicrobial proteins (AMPs) β-defensins (BDs), and promotes epidermal acanthosis and parakeratosis of keratinocytes [90, 118, 119]. Some synergistic effect was noted with other pro-inflammatory cytokines like TNF-α; IFN-γ; and IL-17 [117]. Alone, TNF- α does not have much effect on terminal differentiation of keratinocytes, but when keratinocytes were co-cultured with IL-22 and TNF- α, the effects of IL-22 were amplified. This kind of synergism was also seen with CXCL8 and IL-20 expression in keratinocytes co-stimulated with IL-22 & TNF-α. One possible explanation of this may be that TNF-α increases the expression of IL-22 receptor complex and also affects the IL-22 signaling pathway [115]. Thus, IL-22 and IL-20, but not IFN-γ or IL-17, are the key mediators of resulting epidermal proliferation. IL-22 acts through heterodimeric receptor complex composed of IL-22R1 and IL-10R2 [120]. IL-10R2 chain is ubiquitously expressed in all cells and is important component of receptor complexes required for IL-22, IL-10, IL-26 and IL-28 and IL-29, whereas the IL-22R1 chain is present in epithelial cells and hepatocytes [121]. Between the two subunits, IL-22 binds first to IL-22R1, the high-affinity receptor, and then IL-10R2, a lower affinity receptor [122]. To produce its effect, IL-22 acts through different signaling pathways, mainly signal transducer and activator of transcription 3 (STAT-3) and mitogen activated protein kinase [123].
This final move induces the vicious cycle of proliferation and inflammation of the skin characterized by the hyper-proliferative phenotype of keratinocytes in psoriasis. An anti-IL-22/ IL-20 approach would have a complementary role to the neutralization of p40. However, there has not yet been a human study to demonstrate such a role or anti-IL-22 therapy in the treatment of psoriasis.
Today, reading a book or scientific article on immunopathogensis, one will observe that suppressor T cells, renamed regulatory T cells (Tregs), have become a central concept in immunological vocabulary [124]. Hundreds of publications on Tregs have validated the existence of this single line of T cells. The CD4+CD25+highFoxp3+ Treg subpopulation is developed in the thymus and may be peripherally induced during the course of a normal immune response. The model in which Tregs directly or indirectly modify activation and differentiation of pathogenic T cells by means of an effect on antigen-presenting cells is supported by in vivo analyses [125].
Biological systems are subject to complex regulatory controls and the immune system is no exception. It is known that the immune system has the potential to generate lymphocytes against auto-antigens. Experiments, however, suggest that individuals cannot easily be immunized against their own tissues. Therefore, a suppression mechanism is necessary to control potentially pathogenic immune cells. Owen suggested that this tolerance against one\'s own tissues is acquired during the development of the immune system, and Burnet proposed that the clonal selective destruction of lymphocytes for auto-antigens occurs primarily in the thymus.
The destruction of auto-reactive lymphocytes is the primary mechanism that leads to tolerance, but we know that this system is not perfect. Self-reactive B and T lymphocytes can be isolated from normal individuals [126]. Nishizuka and Sakakura proposed another mechanism for controlling auto-reactive cells. They observed that mice thymectomized between the second and fourth days of life developed an organ-specific autoimmune disease. This target-organ destruction can be prevented by restoring T cells from genetically identical individuals. The generation of regulator T cells was proposed in order to explain this mechanism of auto-tolerance attributed to the thymus [127].
Other studies observed that the prevention of autoimmune diseases was diminished by the reduction of CD4+ T cells, but not of CD8+ T cells, indicating that regulatory cells belonged to the CD4+ T cell class of lymphocytes. Sakaguchi subsequently characterized these regulatory cells as natural CD4+CD25+ Tregs that express Foxp3 [128].
Another control point of the immune response is established when the normal immune response is initiated. A different mechanism must be set off in order to control the magnitude of the response and its subsequent termination. This regulation should contribute to limiting clonal expansion and effector cell activity. Soon after the discovery that T lymphocytes function as helper cells for B-lymphocytes, RK Gershon proposed that they could also act as cells capable of suppressing the immune response [129]. This subpopulation of suppressor T cells was considered a controller of both auto-reactive and effector cells. A suppressor cell was functionally defined as a lymphocyte that inhibits the immune response by influencing the activity of another type of cell involved in a cascade of suppression factors, a network of anti-idiotypic T cells, and counter-suppressive cells [130].
Many of the experiments carried out contain data that support the existence of suppressor T cells. However, the mechanism responsible for these suppressive phenomena was never clearly characterized, and consequently interest in the field of suppressor T cells has gradually dwindled. The discovery of Th1/Th2 cells led researchers to abandon the concept of suppressor T cells. Suppression was instead attributed to counter-regulatory cytokines. As pointed out by Green and Webb, the letter ‘‘S\'\' started to resemble a foul word in cellular immunology, and its use was considered synonymous of scarce data with excessive interpretation or a mystic phenomenon [131].
Suppressor T cells reappeared as regulatory T cells (Tregs) in the late 1990s when several subpopulations of T cells were identified as having the capacity to inhibit the proliferation of other cells. Shevach et al. were the first to call attention to the fact that regulatory T cells and suppressor T cells are the same [132]. Therefore, the term ‘regulatory\' gradually replaced the term ‘suppressor\'. The main problem, however, is not that cells are termed regulatory, but that they are considered to be suppressors. It is more appropriate to consider regulatory T cells as immune response directors instead of its suppressors.
The regulation mechanism of the immune system by CD25+high Tregs is not well understood. Studies have not yet arrived at a simple mode of action. Whatever the mechanism, the homeostatic balance of the immune system is obtained by healthy cellular and humoral responses. Some inflammatory agents, whether physical, chemical, or infectious, induce an intense immune response. This immune response against them frequently results in tissue damage that could be more intense if it were not for the interference of regulatory mechanisms [133]. As has already been specified, Treg cells help limit the damage caused by a vigorous immune response. Natural Treg cells may respond to an ample variety of auto-antigens, although there is evidence that they may also respond to antigens expressed by microbes. Induced regulatory T cells, such as TR1 or Th3, may develop from CD4+ T cells when exposed to specific conditions [134].
Similarly, excessive activity of Treg cells may limit the magnitude of the immune response, which may result in failure to control an infection. On the other hand, the absence of the T regulator may result in intense inflammation and autoimmune dermatitis. Tissue damage may also result from the development of effector cells against their own auto-antigens (Figure 4).
Psoriasis is sustained by the activation of pathogenic T cells. The regulatory expression of skin diseases discusses the action exerted by regulatory T cells, especially CD4+CD25+high Tregs on psoriasis. Various types of influence of these cells suggest that they may act by suppressing or augmenting immunity [135, 136]. The control of Treg cells may affect the results favorably or may be deleterious. There is no definitive view. In psoriasis, studies have shown that the subpopulation of CD4+ T lymphocytes in peripheral blood, phenotypically CD25+high, CTLA-4(+), Foxp3high, is deficient in its suppressor functions. This is associated with an accelerated proliferation of the CD4+ T cell response [137]. The presence of non-functional CD4+CD25+high Treg cells in peripheral blood and in tissues may lead to a reduced capacity to contain pathogenic T cells and to a hyperproliferation of the psoriatic plaque in vivo. These findings represent a critical component of this autoimmune disease and may have implications for potential therapy by manipulation of CD4+CD25+high Tregs in vivo. However, other factors, such as the immune status and genotype, and the presence of concomitant diseases or other infections may also have an influence. The manipulation of this balance can be explored therapeutically.
Immune response regulation mechanisms. The force balance between Tregs and the effector T CD4+ cells may present in a different manner depending on being an autoantigen or a pathogen. In A portion, the clinical expression of autoimmune skin diseases is shown. In this case, there is clinical manifestation only when the number and function of Tregs are significantly reduced. B portion displays clinical manifestations that may occur in extreme cases. In case of excessive Treg function, the result shows reduction of effector lymphocytes against the pathogen, an increase in its number and less tissue damage. The contrary applies to effector cells against the pathogen that surpass the number and function of Treg. The ideal immune and clinical response occurs when there is a balance between functions
An improved understanding of the role of T regulators in psoriasis may lead to the identification of new targets for treatment. More specifically, the goal is to manipulate natural regulator cells or those induced by means of an increase or decrease of their function, depending on the circumstances.
Auto-injections of regulatory T cells are a promising approach to modulation of inflammation and autoimmune diseases [138]. Nevertheless, there is a significant decline in the function of natural CD4+CD25+high Treg cells of peripheral blood in patients with autoimmune diseases when compared to that of healthy individuals. In order to overcome this difficulty, cytokines were used to stimulate the growth of regulator T cells. IL-15 allows a significant in vitro expansion of regulator cells [139]. Natural CD4+CD25+high Treg cells obtained by ex vivo expansion through stimulation with allogeneic antigen-presenting cells and IL-2 were capable of modulating the graft-versus-host disease (GVHD). Induction of natural CD4+CD25+high Treg cells may facilitate the establishment and maintenance of immunological tolerance. Depletion of natural CD4+CD25+high Treg cells may be an effective way of reversing the tolerance induced by malignant tumors and increasing the activity of the immune system against cancer epitopes [140].
In the field of dermatology, the stimulation of Treg cells may be important in autoimmune diseases. For example, blockage of T lymphocyte stimulation, as in the use of the antibody associated with CTLA-4 (cytotoxic T lymphocyte-associated antigen 4-immunoglobulin, CTLA4Ig), reverts the development of psoriatic plaques [141]. In the clinical context, the effect of immunomodulator drugs on these cells warrants attention. For example, tacrolimus, an inhibitor of calcineurin, increases the inhibition of Treg cells in atopic dermatitis [142, 143]. Fludarabine reduces the frequency and suppressive function of natural CD4+CD25+high Treg cells [144]. Low doses of cyclophosphamide induce the inhibition of natural CD4+CD25+high Treg cells and consequently increase the immune response in an apparently paradoxical effect [145]. Along the same line, cyclophosphamide decreases the function, proportion, and number of natural CD4+CD25+high Treg cells that suppress the induction of contact hypersensitivity [146, 147]. Currently, topical corticosteroids constitute one of the most effective treatments for psoriasis and other inflammatory skin diseases. These drugs are effective in inhibiting the function of Th2 cells, eosinophils, and epithelial cells. However, treatment with these drugs during the presentation of the epitope may result in an increased tolerance by suppressing the development of dendrite cells that secrete IL-10, which are necessary for the induction of T regulators. Therefore, treatment with corticosteroids may increase the subsequent effect of the T response and aggravate, on the long run, the course of inflammatory diseases [148]. This aspect may also be related to the rebound effect of inflammatory diseases once these drugs are removed.
Studies suggest that IL-23/Th17/IL-17 immune axis blocking can be used to treat psoriasis [63]. Ustekinumab, anti IL-12/23 antibody, showed its efficacy in ameliorating psoriatic plaques, pruritus, and nail psoriasis [98]. This stimulated growing interest in the therapeutic potential of agents such as brodalumab, ixekizumab, and secukinumab that inhibit interleukin-17 signaling. These new group of biologics are in clinical trials. They use cytokine neutralization and receptor antagonism in treating psoriasis. Secukinumab and ixekizumab specifically neutralize interleukin-17A, whereas brodalumab is an antagonist of the interleukin-17RA receptor [149-151].
As previously mentioned, IL-23 favors the proliferation of the Th17 and consequent production of IL-22. Fezakinumab (ILV-094, Pfizer) is a fully human monoclonal IgGγ antibody to IL-22 under study for the treatment of rheumatoid arthritis and psoriasis [152].
Nonetheless, there is no single new data about the basic mechanisms of psoriasis development despite the cytokine and anti-cytokine therapies widely used.
In medicine, a gold standard is the intervention believed to be the best available option. Given the proven role of many cytokines in psoriasis, substantial interest exists in targeting them with neutralization immunotherapy. If Th1/Th17/Th22 pathways operate in different steps of psoriasis development, then targeted blockade place biologics as the standard-setting paradigm for therapy and understanding of the pathogenesis of psoriasis. However, large studies are needed to provide information on the therapeutic effects, adverse events of any anti-cytokine therapy, and their place in the treatment of psoriasis and other skin diseases. To complement this approach, a detailed comprehension of the associations among the various regulator cells may help in understanding the events leading to the genesis of skin diseases. Ultimately, an ability to manipulate the function of regulator T cells according to the desired therapeutic effect will be the goal. Together, an integrated immunologic approach to therapy holds great promise in reducing the burden of psoriatic disease.
Now that cytokine and anti-cytokine therapies are increasingly used, it is a great opportunity to learn in detail the complex action of these molecules, including both their pro-inflammatory and immunosuppressive properties. The data present above clearly indicate that autoimmunity is a complex system. The immune response seems to be in a constant balancing act with itself. Emerging data indicate that a more realistic view is that these cytokines are not especially loyal to their functions. They switch sides, meaning that they do not have simple pro- or anti-inflammatory actions.
Therefore, the mechanisms of action of the biologic therapies are more intricate than a simple blocking effect. The same cytokine can promote immune and inflammatory responses in some circumstances and inhibit responses in other settings. There is good and bad in every cytokine. Finally, the gut, skin or oral microbial communities simply primes the immune system. Therefore, psoriasis is a game played by many pieces and movements on a complex chessboard. The combinations of movements (cytokines) exert variable effects at different times during the evolution of autoimmune disease. There is much left to be done to dissect the complex and highly interactive effects of the players that one would have thought we understood very well, the Immunology game’s inner logic. The application of game theory to Immunology thinking is our new proposition to explain autoimmune diseases and other immunologic responses. The objective is taking game theory seriously as a potential source of insight into the complex relationships that determine immune system function.
Over the last few decades, the proportion of the world’s population living in urban areas has grown to 55%, and is expected to increase to 68% by 2050 [1]. Africa’s urban growth is unfolding more rapidly than anywhere in the world, with the share of urban dwellers projected to exceed 50% by 2035 [1]. However this growth has been characterized as “rapid, unplanned and unmanaged” because 62% of the urban population in Africa lives in informal settlements characterized by conditions of squalor, overcrowding, and small make-shift structures mostly made of sub-standard housing materials such as mud and scraps of wood or corrugated metal [2]. Unplanned settlement in cities is associated with increased inequality, urban poverty, social deprivation and lifestyle changes that could lead to an increased burden of non-communicable diseases (NCDs) [3]. Thus, changes in physical and social environment in the urban space favor the adoption of behaviors that promote unhealthy lifestyles such as physical inactivity, unhealthy diets, tobacco consumption and harmful alcohol consumption that predispose individuals living in the slums to NCDs [4, 5]. Even so, there is generally lack of consensus as to whether there exists any NCDs health advantages in urban area.
NCDs represent a leading threat to human health and development [6]. In 2015 alone, four major NCDs-cardiovascular diseases (CVDs), cancers, diabetes, and chronic respiratory diseases accounted for 72% of all deaths globally; 85% of these were from low and middle income countries (LMICs) [7]. In urban areas of SSA, NCDs are rising faster than anywhere else in the world [8]. The economic consequences of NCDs are enormous across the globe, and are felt at the individual, household, community and health systems levels. Bloom et al. (2011) [9], estimated that economic losses due to NCDs could amount to approximately 75% of the global GDP. While there is wider recognition of the increasing burden of NCDs across Africa [5], scanty literature exists on the link between urban environments and NCD risks in Africa, as well as the associated health and social consequences, and access to health services. Considering that future population growth will take place predominantly in African cities, there is need for a deeper understanding of urban health and the context of NCDs in African cities to identify tailored interventions to curb the epidemic. Urbanization in sub-Saharan Africa provides a unique opportunity to explore the mechanisms by which urban environment influences NCD epidemiology.
This chapter describes both the health determinants and outcomes in African cities with special attention to low-income urban areas. It further highlights the burden, impact and possible interventions for NCDs in African cities. The chapter draws on insights from relevant peer-reviewed and gray literature on NCDs, and the authors’ own experiences on the subject in Africa.
While the African continent remains largely rural, it is one of the fastest urbanizing regions in the world [1]. Africa’s transition into the ‘urban age’ is seen in the prolific growth of megacities as well as smaller towns [10]. The urban population increased from 14 to 32% between 1950 and 1990 and is projected to rise to 54.1% by the year 2025 [11]. In absolute terms, the urban population will rise from 395 million in 2010 to 1.339 billion in 2050 [12]. Currently, the continent has seven megacities (cities with populations over 10 million): Cairo, Kinshasa, Lagos, Accra, Johannesburg, –Pretoria and Khartoum with cities such as Lagos having an average annual growth rate of 5.8% (Table 1).
Urban population as a percentage of total population* | Urban population average annual growth rate | |||||
---|---|---|---|---|---|---|
1970 | 1991 | 2000 | 1970–1980 | 1980–1990 | 1991–2000 | |
Low-income countries | 28 | 39 (3127) | −3686 | 3.7 | 5 | 2.4 |
Kenya | 10 | 24 (25) | 32 (34) | 8.5 | 7.8 | 7 |
Zimbabwe | 17 | 28 (10) | 35 (12) | 5.6 | 5.8 | 5.4 |
Nigeria | 20 | 36 (99) | 43 (128) | 6.1 | 5.8 | 5.4 |
Urbanization of low-income countries in sub-Saharan Africa.
Figures in parenthesis are estimates of total population in millions.
Other big cities expected to join the megacity list include Nairobi, Luanda, Dar es Salaam and Addis Ababa [13]. Urbanization trends in most of African countries are mainly demographically driven without commensurate socioeconomic development [14]. With no massive social, economic and infrastructural transformations in place, growing cities and towns in Africa experience high rates of poverty, unemployment, low wages and inequality [15, 16]. Urbanization in African is rather chaotic and is dogged with complex urban health crises arising from inadequate safe water supply, squalor and shanty settlements (Figure 1), poor sanitation, poor solid waste and toxins disposal that contaminates food and water [3]. These living conditions drive a high incidence of infectious diseases [17].
Korogocho slums in Nairobi. Credit: APHRC.
Injuries are also common because of inefficient, congested, and risky transport system [18]. It is estimated that up to 62 percent of SSA’s urban population live in informal settlements characterized by pervasive poverty and overcrowding [19]. While the poor in the cities continue to suffer marginalization and experience excess social and economic vulnerability from unstable employment, external shocks such as natural disasters, the affluent section of cities are much more planned and with significant policy attention, and development that ensures healthy living such as presence of walk ways, parks and playing fields (Figure 2) [20, 21]. Therefore, the divide between the rich and poor urban dwellers remains wide in African cities, and the extent of inequality reduces access to healthy living as well as essential and quality health services particularly for the poor. Young people face several challenges when transitioning to adulthood within such settings.
A section of the Nairobi Central Business District (CBD).
There is substantial evidence from studies conducted in Nairobi slums, indicating an increase of smoking along decreasing social economic status (SES) gradient, and within overcrowded settings, thereby elevating the risks of second hand smoking [22]. While urban poverty remains a critical trigger of NCD risks, the existing obesogenic environments and weak health systems in most of urban Africa portend a bleak future for NCD prevention and control. Studies in Kenya, Ghana and South Africa have also shown that living in a city is associated with higher odds of obesity and cardio-metabolic risk factors [23, 24, 25]. Similarly, Peer et al., (2013) [26], in South Africa found that urban environments are associated with an increase in prevalence of the traditional risk factors for NCDs including smoking, harmful alcohol consumption, inadequate physical activity, and inadequate fruit/vegetable consumption. In addition, early life exposure to urban environment has been linked to an increased risk of obesity and impaired fasting glucose in later adulthood [27].
The world health organization (WHO), defines NCDs as any medical condition or disease that is non-infectious and non-transmissible among people. The four main NCDs include cardiovascular diseases, chronic respiratory diseases, diabetes, and cancers which share a set of four key behavioral risk factors: tobacco use, harmful alcohol use, physical inactivity, and unhealthy diet [28]. These behaviors mediate biological risk factors such as obesity, raised blood pressure, and increased blood glucose, elevated blood lipids which ultimately progress to more advanced disease [29]. Other examples of NCDs include mental illnesses, injuries, and chronic kidney diseases. From 1990 to 2015, NCDs related deaths in SSA increased from 25% (1.7 million) to 34% (2.7 million). During the same period, the total NCD burden expressed as disability adjusted life years (DALYs) increased by 45% [7]. Cardiovascular diseases (CVDs) are the leading cause of NCD deaths. In 2013, CVDs caused nearly 1 million deaths in SSA, constituting 38.3% of non-communicable disease deaths and 11.3% of deaths from all causes in the region [30]. Cancers come second causing 12% NCDs deaths with wide variations across regions in SSA. Among males in SSA, leading cancer cases (in age-standardized incidence rate (ASIR) per 100,000 population) included, prostate cancer (27.9), liver cancer (10.2), Kaposi sarcoma (7.2), oesophageal cancer (6.8) and colorectal cancer (6.4). While among females, cervical cancer (34.8), breast cancer (33.8), liver cancer (5.4), colorectal cancer (5.4), ovarian (4.6) [31], are the most common causes of death. Tragically, survival from cancer is worse than in the rest of the world. For many cancers, the risk of getting cancer and the risk of dying from it are nearly the same in SSA [32]. Chronic respiratory diseases and diabetes are each responsible for about 10% and 5% of total deaths in SSA respectively [7]. The NCD risk factors such as high blood pressure, poor diets, air pollution, high body-mass index, tobacco smoking, alcohol and drug use, high fasting plasma glucose, high total cholesterol, and low physical activity are the top 10 global risk factors for death [7].
Other forms of NCDs such as injuries are responsible for a significant proportion of DALYS. Injuries resulting from road accidents (motor vehicles and motor bikes) have increasingly taken a growing toll on human health [33]. Mental disorders, including depression and anxiety, or severe forms like psychosis, schizophrenia and bipolar, as well as alcohol and substance dependence are common. Over the next decade, it is projected that NCD associated DALYs will surpass that contributed by infectious diseases, perinatal and maternal conditions combined (Figure 3).
Projected burden of disease in SSA, 2008 and 2030. Source of data: Authors from (World Health Organization, 2008). NCDS*: Cardiovascular diseases, cancer, diabetes, chronic respiratory diseases.
Hypertension is a leading risk factor for mortality, and is the prime risk factor for the CVD epidemic in Africa [34]. Hypertension is defined as an average systolic blood pressure ≥140 mmHg and/or average diastolic blood pressure ≥90 mmHg among adults aged at least 18 years. Data available on hypertension prevalence are from a wide range of studies [35, 36], majority of which are not age-standardized, and this limits the opportunity for reliable comparison between different African countries and cities. Nevertheless, several WHO STEPwise surveys reported a hypertension prevalence of 19.3–39.6% in Africa [35, 37]. Additional data from epidemiological modeling project suggest that 216.8 million people will have hypertension by 2030. Urban settings consistently have a higher prevalence of hypertension compared to rural areas [38, 39] (Figure 4).
Prevalence of hypertension by rural–urban residence in selected African countries. Source of data: World Health Survey (2003).
Of great concern, is the proportion of individuals with hypertension who remain underdiagnosed, lack access to treatment and are prone to severe complications and increased risk of premature deaths [40]. Evidence from a review of hypertension in 23 African countries, shows that less than half of those with hypertension are aware of their diseases and only one third of those who are aware start treatment, and less than 10% of those on treatment have their blood pressure controlled [41]. It is thus crucial to understand the risk factors driving the rise of hypertension in urban areas to inform preventive interventions. Several factors have been cited as responsible for the rise of hypertension among urban populations in Africa.
Early studies by Donnison et al. (1929) in an African rural community established the role of civilization and urbanization on the development of hypertension [42]. Later, Poulter et al. (1990) established social-behavioral origins with sedentary lifestyles and increased consumption of unhealthy diets among rural–urban migrants in Kenya as major factors driving elevated blood pressure [43]. Researchers also observed that mean diastolic blood pressure of migrants (aged 15–34 years) who moved to the cities increased markedly over time, compared to their controls in the rural areas. In addition, migrants’ mean urinary sodium: potassium ratio, weight and pulse rate were higher than for controls [43]. Cooper et al., also hypothesized that environmental and behavioral changes that occur when individuals move from rural to urban settings all coalesce to increase predisposition to hypertension [44].
Urban poverty which is common in African cities, is also known to mediate deleterious risks factors for hypertension among urban residents [45]. In LMICs, poverty exposes people to behavioral risk factors for NCDs and in turn, resulting NCDs become an important driver for poverty. The urban poor experience increased vulnerability to unhealthy diets and physical inactivity. Evans et al., (2010) found that informal settlements within cities in South Africa had unhealthy diets and inadequate physical activity because they lacked access to organized markets for healthy foods, and had inadequate resources for physical activity [46].
Urban living in South Africa, Tanzania and Cameroon was also reported to be associated with increased exposure to tobacco use, excessive alcohol intake, unhealthy diets (high in salt, and sugar and less in fiber) and also physical inactivity [47, 48]. In the next section, we review how urban environment modifies NCD risk factors.
There is evidence alluding to the link between diet and development of overweight, obesity and occurrence of NCDs [49]. However, the understanding of the nexus between urbanization and changes in dietary patterns and nutrient intakes in Africa remains limited. As African cities grow, the rise in urban population’s increases pressure on arable land for farming, and coupled with rural urban migration, this reduces the ratio of food producers to food consumers [16]. This consequently leads to severe disruptions in healthy food availability, distribution, access and affordability [50, 51]. As healthy foods such as fresh vegetables and fruits, cereals and plant proteins diminish in urban settings, populations resort to the readily available which often unhealthy. A survey in major cities of Cape Verde, Ghana and Senegal reported an increased consumption of energy-dense foods such as candies, ice cream and sweetened beverages up to seven times as frequently as fruit and vegetables [50]. This finding affirms previous studies that showed rapid rise in fat intake across low income countries, including in Africa [52]. Proliferation of fast-food outlets, supermarkets, food vendors, and restaurants in cities have facilitated increased access to unhealthy diets, thus transforming urban settlements into highly obesogenic environments. Nevertheless, for individuals of higher socio-economic status, these changes may offer improved access to nutritious foods since they can afford more healthy foods [53]. While for the urban poor, choices for healthy foods are restricted and they easily resort to the most easily available and affordable diets that are largely unhealthy [54]. In the cities, there are aggressive powerful commercial and emotional advertisements and marketing through various media outlets, which greatly influence preferences and choices of fast-foods and sugary drinks, especially among children and young adults [55, 56].
Physical activity (PA) has many health-promoting effects and is associated with reduced risk of cardiovascular and metabolic diseases, obesity, and some cancers [57]. Insufficient physical activity is a leading risk factor for NCDs and has a negative effect on mental health and quality of life. Levels of physical activity in many African countries vary widely across geographic regions and population subgroups. For instance, country level prevalence of PA ranged from 46.8% in Mali to 96.0% in Mozambique [58]. While current data shows that SSA has the least prevalence of insufficient physical activity compared to the rest of the world [59], trend data shows decreasing levels of physical activity and increasing levels of sedentary lifestyles across all age groups [60]. Country-specific population-based data on physical activity prevalence show lower levels of PA in urban environments attributed to built-up environment leaving no green spaces for physical activity [61]. In addition, congestion in cities, availability of motorized transport and absence of paved walk-ways makes it impractical for physical activity to happen in African cities. In low income informal settlements in African cities, several physical barriers and insecurity limit physical activity [46]. In Kenya for instance, young adults in rural areas were found to be more physically active compared to those in urban areas. A study conducted by Mashili et al. (2018) in Tanzania also found that being employed, higher education and wealth status (mainly among urban residents) were associated with less physically activity [62].
The WHO considers tobacco use as the single leading cause of avoidable death and ill health, contributing to lung cancer, chronic respiratory disease and cardiovascular disease [63]. While the use of cigarette and other tobacco products has declined in high-income countries [64], cigarette use in LMICs including in SSA is rising [65]. Demographic Health Surveys (DHS) conducted in 16 African countries revealed that cigarette use was highest among urban dwellers, less educated, and lower socioeconomic status individuals [66]. Consistent with previous studies in Africa, urban residents are most at risk for cigarette use [67], and start smoking at a younger age [68]. A study by Williams et al., (2008) in Cape Town concluded that urbanicity was associated with smoking attitudes among women [69]. Notably, increased marketing of tobacco products target women and youths in urban SSA [66]. Young adults in African cities, for example in Nairobi, Kigali and Dar-es-salaam, have taken into trendier smoking habits such as “shisha” (pipe smoking) [70, 71, 72]. In addition, since informal settlements in the cities are overcrowded, there is increased the risk of second hand smoking and indoor pollution from cooking– all linked to cardiovascular and respiratory complications [73].
Comparative literature about alcohol use in urban and rural settings is rare. Some studies have linked urban living to the rise of psychological distress and alcohol-related problems. However, there is paucity of research that investigates the link between urbanization stress and alcoholism in SSA [74]. Similarly, harmful use of alcohol is often associated with injuries, violence, crime, suicide and risky sexual behaviors [75].
The link between obesity, poor health outcomes and all-cause mortality is well established. Obesity is known to increase the likelihood of diabetes, hypertension, coronary heart disease, and stroke, certain cancers, obstructive sleep apnoea and osteoarthritis. It also negatively affects reproductive performance [24, 27, 76]. Research evidence now characterizes the rapid rise in obesity levels in urban parts of Africa over the last 25 years as an epidemic. A study in Nairobi informal settlements found three times higher obesity prevalence than that rural areas in Kenya [77]. An analysis of demographic and health survey data from 24 African countries over the past 25 years revealed a consistent increase in obesity levels in all study countries. Obesity more than doubled or tripled in 12 of the 24 countries including Kenya, Benin, Niger, Rwanda, Ivory Coast and Uganda, Zambia, Burkina Faso, Mali, and Malawi, while Tanzania experienced a three-fold increase over the same period [78]. Substantial differences were observed between countries: Egypt and Ghana had the highest prevalence of obesity in the survey estimated at 39 and 22%respectively [79]. Obesity was higher among women aged between 15 and 49 years and those living in urban areas [80]-see Figure 5.
Differences in urban and rural overweight and obesity prevalence in Africa. Source of data: Demographic Health Surveys (DHS).
Several studies have described the role of urbanization in the rising obesity epidemic in the African continent [79, 80, 81]. Urbanization along with socioeconomic transformation lead to increased access to high energy-dense foods and more sedentary lifestyles resulting in a positive energy balance leading to obesity. Access to cheap foods, high in fat and sugar content among the urban poor is easier than in rural communities, thus the higher prevalence of obesity in urban areas [82]. In an analysis of data from seven African countries including Malawi, Senegal, Kenya, Ghana, Tanzania, Niger and Burkina Faso, Ziraba et al., found that the greatest increase in prevalence of overweight and obesity over a ten-year was among the poorest people living in the cities [83].
Many interventions for prevention and control of NCDs exist but because most African countries have limited resources, choices have to be made about which of the interventions are prioritized [84]. WHO proposed several NCD “best-buy” strategies - proven and cost-effective approaches for addressing NCDs- within LMICs through tacking of the modifiable risk factors for NCDs [85]. Examples of the “best buys” include increasing taxes on tobacco and alcohol, legislation to restrict smoking zones, bans on advertising, reducing salt and sugar in food and raising public awareness on dangers of all risk factors for NCD and promoting healthy behaviors. A number of African governments made commitments in domesticating and implementing NCD related international commitments, such as the Global NCD Action Plan 2013–2020 with targets and indicators to accelerate NCD control [86]. Nevertheless, progress has been slow, and in some cases off-track in achieving the NCDs indicators by the set deadlines [87]. Scarcity of resources and several competing priorities in the health sectors across African countries limits the ability of countries to achieve their targets. A recent WHO NCD Progress Monitor report revealed that less than half of WHO Member States have set NCD targets/indicators to track progress of implementing NCD “best buys” [88]. Some of the “best-buys” that have been implemented by African countries include; taxes and legislations to create a protective environment that limits exposure to harmful behaviors especially for the most vulnerable.
Both excise and sales tax on tobacco products in Kenya and South Africa were increased [89]. Similarly, several countries including Botswana, Kenya, The Gambia, Ghana, South Africa, Tanzania, and Zimbabwe have imposed taxes on alcoholic beverages [90]. While the enforcement of the alcohol and tobacco policies may be lacking the needed regulatory teeth, there is some evidence suggesting higher levels of alcohol and tobacco abstinence in countries implementing these interventions compared to countries without any regulations [90]. Between 1993 and 2009, cigarettes sales declined by 30% in South Africa, and the rate of smoking among adults dropped by 25%, even as government revenues from tobacco taxes increased by 800% [91, 92]. South Africa imposed taxes on sugary drinks in 2017, becoming the first African country to do so, in an attempt to reduce excessive consumption of sugary drinks [93], the effect of this is yet to be seen. South Africa also passed a legislation to enforce salt reductions in the food industry by establishing maximum sodium content limits to be achieved by 2019 [94]. Some countries are now pushing for bans on alcohol advertising. In Gambia, alcohol advertising is banned on national television and radio.
Some African cities have chosen a more positive and interactive approach through health promotion such as raising awareness about NCDs and encouraging disease screening through campaigns (e.g. for hypertension and diabetes). Most of these health promotion approaches are aimed at achieving positive health behaviors at individual and community levels [95]. For example in Kigali, Rwanda physical activity is promoted among city residents by encouraging people to leave work early once in a week to engage in physical activity [96]. Such preventive approaches to NCD control targeting the behavioral risk factors are more cost-effective than treating the NCDs. A more concerted, strategic, and multi-sectorial policy approach is essential to help reverse the negative trends of NCDs in urban Africa.
Several challenges hinder efforts to address the NCD burden in cities. The main challenges include lack of data needed to inform primary prevention, care and treatment, low community awareness on NCDs and risk factors, weak policies and poverty in the informal settlements.
Limited availability of representative data on the burden of NCDs in Africa [97], leads to a gross underestimation of burden, thus the inability to lobby for investment in NCD care service delivery. Some countries have collected national NCD data through the NCD WHO STEPwise surveys. Up to 33 countries in WHO African Region have conducted at least one round of STEPwise survey which draws a nationally representative sample and about 19 countries have conducted the global school-based student health surveys (GSHS) [98]. Routine data captured by health facilities on morbidity and mortality could be a potential sources of data, but these data are limited by non-representativeness due to differential use of health services, inaccuracies from paper-based data capture systems, thus the data are largely regarded as of poor quality [99]. Insurance firms also provide important morbidity data, but these have limited value since a small proportion of the population access health insurance. The Global Burden of Disease study combines several datasets to model national NCD morbidity and mortality estimates, but rarely reports NCD burden by rural versus urban locations. Data challenges such as the variation in methodologies used to capture data, the rigor of instruments, sampled populations, design used as well as the variations in how the indicators are defined continue to hamper the comparability and learning across countries [100]. Planning of NCD services without reliable data is almost impossible.
Lack of knowledge and awareness on risk factors at community level hinders healthy behavior change and uptake of early NCD screening and treatment services [101]. A study in Abuja reported a high prevalence of hypertension among the elderly populations, and majority of whom were unaware about their conditions [102]. Other studies have suggested that low levels of knowledge and awareness of hypertension are associated with undiagnosed, severe or complicated, and uncontrolled hypertension [103], lack of patients’ adherence to lifestyle modifications and to medications [104, 105]. Certainly raising awareness particularly on uptake of screening services for most NCDs could be beneficial at both individual and population-levels. And in the context of urban Africa, such efforts could leverage on wide spread mass-media for health promotion. Low levels of NCD awareness or knowledge levels among health workers is also associated with reduced ability for case-finding, treatment and referrals [106].
Urban populations in Africa tend to be very diverse by education, religion, socioeconomic status and culture [5]. As a result, NCD prevention and control policies and programs need to be tailored to cater for variations at population levels [107]. In a review CVD policies in Kenya Asiki et al. (2018) found no standalone policies for CVD management and care but some aspects of CVD policy were covered in general NCD policy document [108]. NCD policies in most African countries suffer the same deficiencies as they do not reflect the typical realities of urban living –pervasive food marketing and complex urban food environments that may offer diversity as well as greater exposure to unhealthy foods [8]. These policies are also not well integrated with policies in other sectors such as spatial planning, infrastructure and housing, transport planning, education policy, access to energy, and water and sanitation policies and interventions [53]. As such minimum intersectoral and multisectoral engagements in policy formulation lead to standalone NCD policies that are not coherent with other policies [90]. Furthermore, national policies and plans for the prevention and control of NCDs often suffer from underfunding [109], and are thus not implemented. In addition, interference from commercial and economic interests of industry for tobacco, alcohol, and food industries makes it difficult to regulate these NCD risk factors as policy makers and law enforcers are often bribed or threatened not to formulate and or implement such policies [110].
Health systems in SSA are characteristically weak and overburdened by the rapidly increasing double burden of communicable diseases and NCDs [17]. With more focus and investment on infectious diseases such as malaria, TB and HIV, very little attention is given to the rising NCD burden in cities [111]. As a consequence, several gaps and missed opportunities exist to offer services for patients and many miss diagnosis, and treatment to when they present to hospitals with other diseases [112]. Inadequate staff and as well as capacity of health staff in most countries, negatively affects NCD prevention and treatment at facilities. For instance, nurses at primary healthcare facilities should have skills to use simple point-of-care equipment such as glucometers for early screening, treatment and referral of individuals with abnormal blood glucose [113]. Frequent stock-outs of medicines and supplies remains a critical barrier to prompt treatment and adherence to these treatments. In Nairobi, Kenya medicines for NCDs are hardly available in public hospitals, and there is lack of integration of NCD services with other chronic diseases such as HIV or TB services [114]. Knowing that interventions targeted against one of the disease burdens will impact the other, it is critical that interventions are conducted jointly instead of competing for limited resources. A study in Malawi reported that the full cost of NCD care is often borne directly by patients through out-of-pocket (OOP) payments individuals [115]. Similarly, a study by Mwai and Muriithi (2016) in Kenya reported that NCDs reduce household income by almost 30%, compared to other general ailments that reduce household income by 13.6%. As a consequence, many people suffering from NCDs in Africa face risks of experiencing catastrophic health expenditures, impoverishment and may be deterred from seeking the care they need [116].
Poverty is common among urban residents in Africa and this plays a fundamental role in the onset, progress and mortality of NCD patients [117]. Studies have suggested that the groups most at risk of NCDs in the next decade will be the urban poor [118]. While NCD epidemiology in high income countries is largely driven by explosion of traditional risk factors in Rwanda, increasing evidence points to a greater contribution of malnutrition, infections, and toxic environments - all exacerbated by poverty [119]. Poverty also limits access to quality NCD care. Majority of the urban poor lack access to health insurance and therefore resort to out-of-pocket payments, consequently leading to catastrophic spending [120]. Research on social and economic implications of NCDs remain scarce in most SSA countries yet such information is important for prioritization of NCDs by all relevant sectors [121].
The rapid urbanization in Africa continues to drive the NCD epidemic, increasing vulnerability of individuals, threatening development and sustainability of African cities. To mitigate this rising threat - effective evidence-informed multi-sectoral policies are needed to address prevention and control of NCD focusing on the major NCD risk factors. While several countries have developed national strategies for NCD prevention following the global WHO NCD prevention strategies, implementation of these policies is still inadequate. Thus there is need for governments to put more effort in strengthening implementation of these policies including allocation of financial and other resources to support implementation. NCD policies need to be integrated into urban planning to address air pollution as well as physical inactivity by designing and developing parks and recreational facilities including pedestrian and cycling tracks, zoning walk-ways where motorized vehicles are not allowed and providing incentives for the non-use of motorized vehicles. Fiscal policies and regulatory measures to restrict unhealthy food environment in urban areas of Africa are also needed to curtail the ever growing food marketing by a burgeoning food industry.
There is need to strengthen health care systems to make them more responsive to NCD prevention and control. This include building capacity of health workforce on prevention and control of NCDs, strengthening infrastructure, providing essential commodities and supplies and strengthen surveillance systems to be able to plan, monitor, and assess the effects of NCDs on population health and monitor the performance of interventions. A good balance of investment is required for the delivery and coordination of both curative and preventive and promotive services to avert the NCD disease burden. Countries need to explore various models of partnership with private sector partners aimed at scaling up their contributions to addressing NCDs directly or indirectly through various multi-sectoral strategies.
There is need to strengthen primary prevention interventions at community-levels. These interventions include early detection, active screening, case finding, referral and treatment and working with at-risk individuals to reduce high risk behavior. Expanding opportunities for early detection at the community and in primary health facilities could yield positive outcomes, especially through deliberate implementation of task shifting and task sharing models, involving community health workers (CHWs), while consistently mentoring and evaluating performance of such a model. Further community interventions include health education and promotion focusing on NCD risk factors including importance of reduced alcohol and tobacco consumption, physical activity and decreased consumption of high-calorie foods and highly processed foods while increasing consumption of fruits and vegetables. Some evidence exist on the potential positive results of such small-scale healthy food interventions utilizing platforms such as school feeding programs and workplaces. While documented community interventions addressing alcohol and tobacco consumption are scarce, interventions to enhance awareness and engagement in physical activity in major cities such as in Rwanda and Cameroon have been shown to work. Above all pro-poor primary health care programs targeting vulnerable and disadvantaged groups in African cities are needed to reduce the equity gap in NCD services.
Content alerts
",metaTitle:"Content alerts",metaDescription:"Content alerts",metaKeywords:null,canonicalURL:"/page/content-alerts",contentRaw:'[{"type":"htmlEditorComponent","content":"Content alerts
\\n"}]'},components:[{type:"htmlEditorComponent",content:"Content alerts
\n"}]},successStories:{items:[]},authorsAndEditors:{filterParams:{sort:"featured,name"},profiles:[{id:"6700",title:"Dr.",name:"Abbass A.",middleName:null,surname:"Hashim",slug:"abbass-a.-hashim",fullName:"Abbass A. Hashim",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/6700/images/1864_n.jpg",biography:"Currently I am carrying out research in several areas of interest, mainly covering work on chemical and bio-sensors, semiconductor thin film device fabrication and characterisation.\nAt the moment I have very strong interest in radiation environmental pollution and bacteriology treatment. The teams of researchers are working very hard to bring novel results in this field. I am also a member of the team in charge for the supervision of Ph.D. students in the fields of development of silicon based planar waveguide sensor devices, study of inelastic electron tunnelling in planar tunnelling nanostructures for sensing applications and development of organotellurium(IV) compounds for semiconductor applications. I am a specialist in data analysis techniques and nanosurface structure. I have served as the editor for many books, been a member of the editorial board in science journals, have published many papers and hold many patents.",institutionString:null,institution:{name:"Sheffield Hallam University",country:{name:"United Kingdom"}}},{id:"54525",title:"Prof.",name:"Abdul Latif",middleName:null,surname:"Ahmad",slug:"abdul-latif-ahmad",fullName:"Abdul Latif Ahmad",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"20567",title:"Prof.",name:"Ado",middleName:null,surname:"Jorio",slug:"ado-jorio",fullName:"Ado Jorio",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Universidade Federal de Minas Gerais",country:{name:"Brazil"}}},{id:"47940",title:"Dr.",name:"Alberto",middleName:null,surname:"Mantovani",slug:"alberto-mantovani",fullName:"Alberto Mantovani",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"12392",title:"Mr.",name:"Alex",middleName:null,surname:"Lazinica",slug:"alex-lazinica",fullName:"Alex Lazinica",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/12392/images/7282_n.png",biography:"Alex Lazinica is the founder and CEO of IntechOpen. After obtaining a Master's degree in Mechanical Engineering, he continued his PhD studies in Robotics at the Vienna University of Technology. Here he worked as a robotic researcher with the university's Intelligent Manufacturing Systems Group as well as a guest researcher at various European universities, including the Swiss Federal Institute of Technology Lausanne (EPFL). During this time he published more than 20 scientific papers, gave presentations, served as a reviewer for major robotic journals and conferences and most importantly he co-founded and built the International Journal of Advanced Robotic Systems- world's first Open Access journal in the field of robotics. Starting this journal was a pivotal point in his career, since it was a pathway to founding IntechOpen - Open Access publisher focused on addressing academic researchers needs. Alex is a personification of IntechOpen key values being trusted, open and entrepreneurial. Today his focus is on defining the growth and development strategy for the company.",institutionString:null,institution:{name:"TU Wien",country:{name:"Austria"}}},{id:"19816",title:"Prof.",name:"Alexander",middleName:null,surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/19816/images/1607_n.jpg",biography:"Alexander I. Kokorin: born: 1947, Moscow; DSc., PhD; Principal Research Fellow (Research Professor) of Department of Kinetics and Catalysis, N. Semenov Institute of Chemical Physics, Russian Academy of Sciences, Moscow.\r\nArea of research interests: physical chemistry of complex-organized molecular and nanosized systems, including polymer-metal complexes; the surface of doped oxide semiconductors. He is an expert in structural, absorptive, catalytic and photocatalytic properties, in structural organization and dynamic features of ionic liquids, in magnetic interactions between paramagnetic centers. The author or co-author of 3 books, over 200 articles and reviews in scientific journals and books. He is an actual member of the International EPR/ESR Society, European Society on Quantum Solar Energy Conversion, Moscow House of Scientists, of the Board of Moscow Physical Society.",institutionString:null,institution:{name:"Semenov Institute of Chemical Physics",country:{name:"Russia"}}},{id:"62389",title:"PhD.",name:"Ali Demir",middleName:null,surname:"Sezer",slug:"ali-demir-sezer",fullName:"Ali Demir Sezer",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/62389/images/3413_n.jpg",biography:"Dr. Ali Demir Sezer has a Ph.D. from Pharmaceutical Biotechnology at the Faculty of Pharmacy, University of Marmara (Turkey). He is the member of many Pharmaceutical Associations and acts as a reviewer of scientific journals and European projects under different research areas such as: drug delivery systems, nanotechnology and pharmaceutical biotechnology. Dr. Sezer is the author of many scientific publications in peer-reviewed journals and poster communications. Focus of his research activity is drug delivery, physico-chemical characterization and biological evaluation of biopolymers micro and nanoparticles as modified drug delivery system, and colloidal drug carriers (liposomes, nanoparticles etc.).",institutionString:null,institution:{name:"Marmara University",country:{name:"Turkey"}}},{id:"61051",title:"Prof.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"100762",title:"Prof.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"St David's Medical Center",country:{name:"United States of America"}}},{id:"107416",title:"Dr.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Texas Cardiac Arrhythmia",country:{name:"United States of America"}}},{id:"64434",title:"Dr.",name:"Angkoon",middleName:null,surname:"Phinyomark",slug:"angkoon-phinyomark",fullName:"Angkoon Phinyomark",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/64434/images/2619_n.jpg",biography:"My name is Angkoon Phinyomark. I received a B.Eng. degree in Computer Engineering with First Class Honors in 2008 from Prince of Songkla University, Songkhla, Thailand, where I received a Ph.D. degree in Electrical Engineering. My research interests are primarily in the area of biomedical signal processing and classification notably EMG (electromyography signal), EOG (electrooculography signal), and EEG (electroencephalography signal), image analysis notably breast cancer analysis and optical coherence tomography, and rehabilitation engineering. I became a student member of IEEE in 2008. During October 2011-March 2012, I had worked at School of Computer Science and Electronic Engineering, University of Essex, Colchester, Essex, United Kingdom. In addition, during a B.Eng. I had been a visiting research student at Faculty of Computer Science, University of Murcia, Murcia, Spain for three months.\n\nI have published over 40 papers during 5 years in refereed journals, books, and conference proceedings in the areas of electro-physiological signals processing and classification, notably EMG and EOG signals, fractal analysis, wavelet analysis, texture analysis, feature extraction and machine learning algorithms, and assistive and rehabilitative devices. I have several computer programming language certificates, i.e. Sun Certified Programmer for the Java 2 Platform 1.4 (SCJP), Microsoft Certified Professional Developer, Web Developer (MCPD), Microsoft Certified Technology Specialist, .NET Framework 2.0 Web (MCTS). I am a Reviewer for several refereed journals and international conferences, such as IEEE Transactions on Biomedical Engineering, IEEE Transactions on Industrial Electronics, Optic Letters, Measurement Science Review, and also a member of the International Advisory Committee for 2012 IEEE Business Engineering and Industrial Applications and 2012 IEEE Symposium on Business, Engineering and Industrial Applications.",institutionString:null,institution:{name:"Joseph Fourier University",country:{name:"France"}}},{id:"55578",title:"Dr.",name:"Antonio",middleName:null,surname:"Jurado-Navas",slug:"antonio-jurado-navas",fullName:"Antonio Jurado-Navas",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/55578/images/4574_n.png",biography:"Antonio Jurado-Navas received the M.S. degree (2002) and the Ph.D. degree (2009) in Telecommunication Engineering, both from the University of Málaga (Spain). He first worked as a consultant at Vodafone-Spain. From 2004 to 2011, he was a Research Assistant with the Communications Engineering Department at the University of Málaga. In 2011, he became an Assistant Professor in the same department. From 2012 to 2015, he was with Ericsson Spain, where he was working on geo-location\ntools for third generation mobile networks. Since 2015, he is a Marie-Curie fellow at the Denmark Technical University. His current research interests include the areas of mobile communication systems and channel modeling in addition to atmospheric optical communications, adaptive optics and statistics",institutionString:null,institution:{name:"University of Malaga",country:{name:"Spain"}}}],filtersByRegion:[{group:"region",caption:"North America",value:1,count:5766},{group:"region",caption:"Middle and South America",value:2,count:5227},{group:"region",caption:"Africa",value:3,count:1717},{group:"region",caption:"Asia",value:4,count:10366},{group:"region",caption:"Australia and Oceania",value:5,count:897},{group:"region",caption:"Europe",value:6,count:15789}],offset:12,limit:12,total:118187},chapterEmbeded:{data:{}},editorApplication:{success:null,errors:{}},ofsBooks:{filterParams:{sort:"dateEndThirdStepPublish"},books:[{type:"book",id:"10231",title:"Proton Therapy",subtitle:null,isOpenForSubmission:!0,hash:"f4a9009287953c8d1d89f0fa9b7597b0",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10231.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10652",title:"Visual Object Tracking",subtitle:null,isOpenForSubmission:!0,hash:"96f3ee634a7ba49fa195e50475412af4",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10652.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10653",title:"Optimization Algorithms",subtitle:null,isOpenForSubmission:!0,hash:"753812dbb9a6f6b57645431063114f6c",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10653.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10655",title:"Motion Planning",subtitle:null,isOpenForSubmission:!0,hash:"809b5e290cf2dade9e7e0a5ae0ef3df0",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10655.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10657",title:"Service Robots",subtitle:null,isOpenForSubmission:!0,hash:"5f81b9eea6eb3f9af984031b7af35588",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10657.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10662",title:"Pedagogy",subtitle:null,isOpenForSubmission:!0,hash:"c858e1c6fb878d3b895acbacec624576",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10662.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10673",title:"The Psychology of Trust",subtitle:null,isOpenForSubmission:!0,hash:"1f6cac41fd145f718ac0866264499cc8",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10673.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10675",title:"Hydrostatics",subtitle:null,isOpenForSubmission:!0,hash:"c86c2fa9f835d4ad5e7efd8b01921866",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10675.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10677",title:"Topology",subtitle:null,isOpenForSubmission:!0,hash:"85eac84b173d785f989522397616124e",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10677.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10678",title:"Biostatistics",subtitle:null,isOpenForSubmission:!0,hash:"f63db439474a574454a66894db8b394c",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10678.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10679",title:"Mass Production",subtitle:null,isOpenForSubmission:!0,hash:"2dae91102099b1a07be1a36a68852829",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10679.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10684",title:"Biorefineries",subtitle:null,isOpenForSubmission:!0,hash:"23962c6b77348bcbf247c673d34562f6",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10684.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],filtersByTopic:[{group:"topic",caption:"Agricultural and Biological Sciences",value:5,count:14},{group:"topic",caption:"Biochemistry, Genetics and Molecular Biology",value:6,count:3},{group:"topic",caption:"Business, Management and Economics",value:7,count:1},{group:"topic",caption:"Chemistry",value:8,count:6},{group:"topic",caption:"Computer and Information Science",value:9,count:7},{group:"topic",caption:"Earth and Planetary Sciences",value:10,count:7},{group:"topic",caption:"Engineering",value:11,count:15},{group:"topic",caption:"Environmental Sciences",value:12,count:2},{group:"topic",caption:"Immunology and Microbiology",value:13,count:3},{group:"topic",caption:"Materials Science",value:14,count:5},{group:"topic",caption:"Mathematics",value:15,count:1},{group:"topic",caption:"Medicine",value:16,count:29},{group:"topic",caption:"Neuroscience",value:18,count:1},{group:"topic",caption:"Pharmacology, Toxicology and Pharmaceutical Science",value:19,count:2},{group:"topic",caption:"Physics",value:20,count:2},{group:"topic",caption:"Psychology",value:21,count:4},{group:"topic",caption:"Social Sciences",value:23,count:2},{group:"topic",caption:"Technology",value:24,count:1},{group:"topic",caption:"Veterinary Medicine and Science",value:25,count:1}],offset:12,limit:12,total:193},popularBooks:{featuredBooks:[{type:"book",id:"9385",title:"Renewable Energy",subtitle:"Technologies and Applications",isOpenForSubmission:!1,hash:"a6b446d19166f17f313008e6c056f3d8",slug:"renewable-energy-technologies-and-applications",bookSignature:"Tolga Taner, Archana Tiwari and Taha Selim Ustun",coverURL:"https://cdn.intechopen.com/books/images_new/9385.jpg",editors:[{id:"197240",title:"Associate Prof.",name:"Tolga",middleName:null,surname:"Taner",slug:"tolga-taner",fullName:"Tolga Taner"}],equalEditorOne:{id:"186791",title:"Dr.",name:"Archana",middleName:null,surname:"Tiwari",slug:"archana-tiwari",fullName:"Archana Tiwari",profilePictureURL:"https://mts.intechopen.com/storage/users/186791/images/system/186791.jpg",biography:"Dr. Archana Tiwari is Associate Professor at Amity University, India. Her research interests include renewable sources of energy from microalgae and further utilizing the residual biomass for the generation of value-added products, bioremediation through microalgae and microbial consortium, antioxidative enzymes and stress, and nutraceuticals from microalgae. She has been working on algal biotechnology for the last two decades. She has published her research in many international journals and has authored many books and chapters with renowned publishing houses. She has also delivered talks as an invited speaker at many national and international conferences. Dr. Tiwari is the recipient of several awards including Researcher of the Year and Distinguished Scientist.",institutionString:"Amity University",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"1",institution:{name:"Amity University",institutionURL:null,country:{name:"India"}}},equalEditorTwo:{id:"197609",title:"Prof.",name:"Taha Selim",middleName:null,surname:"Ustun",slug:"taha-selim-ustun",fullName:"Taha Selim Ustun",profilePictureURL:"https://mts.intechopen.com/storage/users/197609/images/system/197609.jpeg",biography:"Dr. Taha Selim Ustun received a Ph.D. in Electrical Engineering from Victoria University, Melbourne, Australia. He is a researcher with the Fukushima Renewable Energy Institute, AIST (FREA), where he leads the Smart Grid Cybersecurity Laboratory. Prior to that, he was a faculty member with the School of Electrical and Computer Engineering, Carnegie Mellon University, Pittsburgh, PA, USA. His current research interests include power systems protection, communication in power networks, distributed generation, microgrids, electric vehicle integration, and cybersecurity in smart grids. He serves on the editorial boards of IEEE Access, IEEE Transactions on Industrial Informatics, Energies, Electronics, Electricity, World Electric Vehicle and Information journals. Dr. Ustun is a member of the IEEE 2004 and 2800, IEC Renewable Energy Management WG 8, and IEC TC 57 WG17. He has been invited to run specialist courses in Africa, India, and China. He has delivered talks for the Qatar Foundation, the World Energy Council, the Waterloo Global Science Initiative, and the European Union Energy Initiative (EUEI). His research has attracted funding from prestigious programs in Japan, Australia, the European Union, and North America.",institutionString:"Fukushima Renewable Energy Institute, AIST (FREA)",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"1",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"National Institute of Advanced Industrial Science and Technology",institutionURL:null,country:{name:"Japan"}}},equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8985",title:"Natural Resources Management and Biological Sciences",subtitle:null,isOpenForSubmission:!1,hash:"5c2e219a6c021a40b5a20c041dea88c4",slug:"natural-resources-management-and-biological-sciences",bookSignature:"Edward R. Rhodes and Humood Naser",coverURL:"https://cdn.intechopen.com/books/images_new/8985.jpg",editors:[{id:"280886",title:"Prof.",name:"Edward R",middleName:null,surname:"Rhodes",slug:"edward-r-rhodes",fullName:"Edward R Rhodes"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9027",title:"Human Blood Group Systems and Haemoglobinopathies",subtitle:null,isOpenForSubmission:!1,hash:"d00d8e40b11cfb2547d1122866531c7e",slug:"human-blood-group-systems-and-haemoglobinopathies",bookSignature:"Osaro Erhabor and Anjana Munshi",coverURL:"https://cdn.intechopen.com/books/images_new/9027.jpg",editors:[{id:"35140",title:null,name:"Osaro",middleName:null,surname:"Erhabor",slug:"osaro-erhabor",fullName:"Osaro Erhabor"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7841",title:"New Insights Into Metabolic Syndrome",subtitle:null,isOpenForSubmission:!1,hash:"ef5accfac9772b9e2c9eff884f085510",slug:"new-insights-into-metabolic-syndrome",bookSignature:"Akikazu Takada",coverURL:"https://cdn.intechopen.com/books/images_new/7841.jpg",editors:[{id:"248459",title:"Dr.",name:"Akikazu",middleName:null,surname:"Takada",slug:"akikazu-takada",fullName:"Akikazu Takada"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8558",title:"Aerodynamics",subtitle:null,isOpenForSubmission:!1,hash:"db7263fc198dfb539073ba0260a7f1aa",slug:"aerodynamics",bookSignature:"Mofid Gorji-Bandpy and Aly-Mousaad Aly",coverURL:"https://cdn.intechopen.com/books/images_new/8558.jpg",editors:[{id:"35542",title:"Prof.",name:"Mofid",middleName:null,surname:"Gorji-Bandpy",slug:"mofid-gorji-bandpy",fullName:"Mofid Gorji-Bandpy"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9668",title:"Chemistry and Biochemistry of Winemaking, Wine Stabilization and Aging",subtitle:null,isOpenForSubmission:!1,hash:"c5484276a314628acf21ec1bdc3a86b9",slug:"chemistry-and-biochemistry-of-winemaking-wine-stabilization-and-aging",bookSignature:"Fernanda Cosme, Fernando M. Nunes and Luís Filipe-Ribeiro",coverURL:"https://cdn.intechopen.com/books/images_new/9668.jpg",editors:[{id:"186819",title:"Prof.",name:"Fernanda",middleName:null,surname:"Cosme",slug:"fernanda-cosme",fullName:"Fernanda Cosme"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7847",title:"Medical Toxicology",subtitle:null,isOpenForSubmission:!1,hash:"db9b65bea093de17a0855a1b27046247",slug:"medical-toxicology",bookSignature:"Pınar Erkekoglu and Tomohisa Ogawa",coverURL:"https://cdn.intechopen.com/books/images_new/7847.jpg",editors:[{id:"109978",title:"Prof.",name:"Pınar",middleName:null,surname:"Erkekoglu",slug:"pinar-erkekoglu",fullName:"Pınar Erkekoglu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8620",title:"Mining Techniques",subtitle:"Past, Present and Future",isOpenForSubmission:!1,hash:"b65658f81d14e9e57e49377869d3a575",slug:"mining-techniques-past-present-and-future",bookSignature:"Abhay Soni",coverURL:"https://cdn.intechopen.com/books/images_new/8620.jpg",editors:[{id:"271093",title:"Dr.",name:"Abhay",middleName:null,surname:"Soni",slug:"abhay-soni",fullName:"Abhay Soni"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9660",title:"Inland Waters",subtitle:"Dynamics and Ecology",isOpenForSubmission:!1,hash:"975c26819ceb11a926793bc2adc62bd6",slug:"inland-waters-dynamics-and-ecology",bookSignature:"Adam Devlin, Jiayi Pan and Mohammad Manjur Shah",coverURL:"https://cdn.intechopen.com/books/images_new/9660.jpg",editors:[{id:"280757",title:"Dr.",name:"Adam",middleName:"Thomas",surname:"Devlin",slug:"adam-devlin",fullName:"Adam Devlin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9122",title:"Cosmetic Surgery",subtitle:null,isOpenForSubmission:!1,hash:"207026ca4a4125e17038e770d00ee152",slug:"cosmetic-surgery",bookSignature:"Yueh-Bih Tang",coverURL:"https://cdn.intechopen.com/books/images_new/9122.jpg",editors:[{id:"202122",title:"Prof.",name:"Yueh-Bih",middleName:null,surname:"Tang",slug:"yueh-bih-tang",fullName:"Yueh-Bih Tang"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9043",title:"Parenting",subtitle:"Studies by an Ecocultural and Transactional Perspective",isOpenForSubmission:!1,hash:"6d21066c7438e459e4c6fb13217a5c8c",slug:"parenting-studies-by-an-ecocultural-and-transactional-perspective",bookSignature:"Loredana Benedetto and Massimo Ingrassia",coverURL:"https://cdn.intechopen.com/books/images_new/9043.jpg",editors:[{id:"193200",title:"Prof.",name:"Loredana",middleName:null,surname:"Benedetto",slug:"loredana-benedetto",fullName:"Loredana Benedetto"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9731",title:"Oxidoreductase",subtitle:null,isOpenForSubmission:!1,hash:"852e6f862c85fc3adecdbaf822e64e6e",slug:"oxidoreductase",bookSignature:"Mahmoud Ahmed Mansour",coverURL:"https://cdn.intechopen.com/books/images_new/9731.jpg",editors:[{id:"224662",title:"Prof.",name:"Mahmoud Ahmed",middleName:null,surname:"Mansour",slug:"mahmoud-ahmed-mansour",fullName:"Mahmoud Ahmed Mansour"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],offset:12,limit:12,total:5221},hotBookTopics:{hotBooks:[],offset:0,limit:12,total:null},publish:{},publishingProposal:{success:null,errors:{}},books:{featuredBooks:[{type:"book",id:"9385",title:"Renewable Energy",subtitle:"Technologies and Applications",isOpenForSubmission:!1,hash:"a6b446d19166f17f313008e6c056f3d8",slug:"renewable-energy-technologies-and-applications",bookSignature:"Tolga Taner, Archana Tiwari and Taha Selim Ustun",coverURL:"https://cdn.intechopen.com/books/images_new/9385.jpg",editors:[{id:"197240",title:"Associate Prof.",name:"Tolga",middleName:null,surname:"Taner",slug:"tolga-taner",fullName:"Tolga Taner"}],equalEditorOne:{id:"186791",title:"Dr.",name:"Archana",middleName:null,surname:"Tiwari",slug:"archana-tiwari",fullName:"Archana Tiwari",profilePictureURL:"https://mts.intechopen.com/storage/users/186791/images/system/186791.jpg",biography:"Dr. Archana Tiwari is Associate Professor at Amity University, India. Her research interests include renewable sources of energy from microalgae and further utilizing the residual biomass for the generation of value-added products, bioremediation through microalgae and microbial consortium, antioxidative enzymes and stress, and nutraceuticals from microalgae. She has been working on algal biotechnology for the last two decades. She has published her research in many international journals and has authored many books and chapters with renowned publishing houses. She has also delivered talks as an invited speaker at many national and international conferences. Dr. Tiwari is the recipient of several awards including Researcher of the Year and Distinguished Scientist.",institutionString:"Amity University",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"1",institution:{name:"Amity University",institutionURL:null,country:{name:"India"}}},equalEditorTwo:{id:"197609",title:"Prof.",name:"Taha Selim",middleName:null,surname:"Ustun",slug:"taha-selim-ustun",fullName:"Taha Selim Ustun",profilePictureURL:"https://mts.intechopen.com/storage/users/197609/images/system/197609.jpeg",biography:"Dr. Taha Selim Ustun received a Ph.D. in Electrical Engineering from Victoria University, Melbourne, Australia. He is a researcher with the Fukushima Renewable Energy Institute, AIST (FREA), where he leads the Smart Grid Cybersecurity Laboratory. Prior to that, he was a faculty member with the School of Electrical and Computer Engineering, Carnegie Mellon University, Pittsburgh, PA, USA. His current research interests include power systems protection, communication in power networks, distributed generation, microgrids, electric vehicle integration, and cybersecurity in smart grids. He serves on the editorial boards of IEEE Access, IEEE Transactions on Industrial Informatics, Energies, Electronics, Electricity, World Electric Vehicle and Information journals. Dr. Ustun is a member of the IEEE 2004 and 2800, IEC Renewable Energy Management WG 8, and IEC TC 57 WG17. He has been invited to run specialist courses in Africa, India, and China. He has delivered talks for the Qatar Foundation, the World Energy Council, the Waterloo Global Science Initiative, and the European Union Energy Initiative (EUEI). His research has attracted funding from prestigious programs in Japan, Australia, the European Union, and North America.",institutionString:"Fukushima Renewable Energy Institute, AIST (FREA)",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"1",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"National Institute of Advanced Industrial Science and Technology",institutionURL:null,country:{name:"Japan"}}},equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8985",title:"Natural Resources Management and Biological Sciences",subtitle:null,isOpenForSubmission:!1,hash:"5c2e219a6c021a40b5a20c041dea88c4",slug:"natural-resources-management-and-biological-sciences",bookSignature:"Edward R. Rhodes and Humood Naser",coverURL:"https://cdn.intechopen.com/books/images_new/8985.jpg",editors:[{id:"280886",title:"Prof.",name:"Edward R",middleName:null,surname:"Rhodes",slug:"edward-r-rhodes",fullName:"Edward R Rhodes"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9027",title:"Human Blood Group Systems and Haemoglobinopathies",subtitle:null,isOpenForSubmission:!1,hash:"d00d8e40b11cfb2547d1122866531c7e",slug:"human-blood-group-systems-and-haemoglobinopathies",bookSignature:"Osaro Erhabor and Anjana Munshi",coverURL:"https://cdn.intechopen.com/books/images_new/9027.jpg",editors:[{id:"35140",title:null,name:"Osaro",middleName:null,surname:"Erhabor",slug:"osaro-erhabor",fullName:"Osaro Erhabor"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7841",title:"New Insights Into Metabolic Syndrome",subtitle:null,isOpenForSubmission:!1,hash:"ef5accfac9772b9e2c9eff884f085510",slug:"new-insights-into-metabolic-syndrome",bookSignature:"Akikazu Takada",coverURL:"https://cdn.intechopen.com/books/images_new/7841.jpg",editors:[{id:"248459",title:"Dr.",name:"Akikazu",middleName:null,surname:"Takada",slug:"akikazu-takada",fullName:"Akikazu Takada"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8558",title:"Aerodynamics",subtitle:null,isOpenForSubmission:!1,hash:"db7263fc198dfb539073ba0260a7f1aa",slug:"aerodynamics",bookSignature:"Mofid Gorji-Bandpy and Aly-Mousaad Aly",coverURL:"https://cdn.intechopen.com/books/images_new/8558.jpg",editors:[{id:"35542",title:"Prof.",name:"Mofid",middleName:null,surname:"Gorji-Bandpy",slug:"mofid-gorji-bandpy",fullName:"Mofid Gorji-Bandpy"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9668",title:"Chemistry and Biochemistry of Winemaking, Wine Stabilization and Aging",subtitle:null,isOpenForSubmission:!1,hash:"c5484276a314628acf21ec1bdc3a86b9",slug:"chemistry-and-biochemistry-of-winemaking-wine-stabilization-and-aging",bookSignature:"Fernanda Cosme, Fernando M. Nunes and Luís Filipe-Ribeiro",coverURL:"https://cdn.intechopen.com/books/images_new/9668.jpg",editors:[{id:"186819",title:"Prof.",name:"Fernanda",middleName:null,surname:"Cosme",slug:"fernanda-cosme",fullName:"Fernanda Cosme"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7847",title:"Medical Toxicology",subtitle:null,isOpenForSubmission:!1,hash:"db9b65bea093de17a0855a1b27046247",slug:"medical-toxicology",bookSignature:"Pınar Erkekoglu and Tomohisa Ogawa",coverURL:"https://cdn.intechopen.com/books/images_new/7847.jpg",editors:[{id:"109978",title:"Prof.",name:"Pınar",middleName:null,surname:"Erkekoglu",slug:"pinar-erkekoglu",fullName:"Pınar Erkekoglu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8620",title:"Mining Techniques",subtitle:"Past, Present and Future",isOpenForSubmission:!1,hash:"b65658f81d14e9e57e49377869d3a575",slug:"mining-techniques-past-present-and-future",bookSignature:"Abhay Soni",coverURL:"https://cdn.intechopen.com/books/images_new/8620.jpg",editors:[{id:"271093",title:"Dr.",name:"Abhay",middleName:null,surname:"Soni",slug:"abhay-soni",fullName:"Abhay Soni"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9660",title:"Inland Waters",subtitle:"Dynamics and Ecology",isOpenForSubmission:!1,hash:"975c26819ceb11a926793bc2adc62bd6",slug:"inland-waters-dynamics-and-ecology",bookSignature:"Adam Devlin, Jiayi Pan and Mohammad Manjur Shah",coverURL:"https://cdn.intechopen.com/books/images_new/9660.jpg",editors:[{id:"280757",title:"Dr.",name:"Adam",middleName:"Thomas",surname:"Devlin",slug:"adam-devlin",fullName:"Adam Devlin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9122",title:"Cosmetic Surgery",subtitle:null,isOpenForSubmission:!1,hash:"207026ca4a4125e17038e770d00ee152",slug:"cosmetic-surgery",bookSignature:"Yueh-Bih Tang",coverURL:"https://cdn.intechopen.com/books/images_new/9122.jpg",editors:[{id:"202122",title:"Prof.",name:"Yueh-Bih",middleName:null,surname:"Tang",slug:"yueh-bih-tang",fullName:"Yueh-Bih Tang"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],latestBooks:[{type:"book",id:"9550",title:"Entrepreneurship",subtitle:"Contemporary Issues",isOpenForSubmission:!1,hash:"9b4ac1ee5b743abf6f88495452b1e5e7",slug:"entrepreneurship-contemporary-issues",bookSignature:"Mladen Turuk",coverURL:"https://cdn.intechopen.com/books/images_new/9550.jpg",editedByType:"Edited by",editors:[{id:"319755",title:"Prof.",name:"Mladen",middleName:null,surname:"Turuk",slug:"mladen-turuk",fullName:"Mladen Turuk"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10065",title:"Wavelet Theory",subtitle:null,isOpenForSubmission:!1,hash:"d8868e332169597ba2182d9b004d60de",slug:"wavelet-theory",bookSignature:"Somayeh Mohammady",coverURL:"https://cdn.intechopen.com/books/images_new/10065.jpg",editedByType:"Edited by",editors:[{id:"109280",title:"Dr.",name:"Somayeh",middleName:null,surname:"Mohammady",slug:"somayeh-mohammady",fullName:"Somayeh Mohammady"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9313",title:"Clay Science and Technology",subtitle:null,isOpenForSubmission:!1,hash:"6fa7e70396ff10620e032bb6cfa6fb72",slug:"clay-science-and-technology",bookSignature:"Gustavo Morari Do Nascimento",coverURL:"https://cdn.intechopen.com/books/images_new/9313.jpg",editedByType:"Edited by",editors:[{id:"7153",title:"Prof.",name:"Gustavo",middleName:null,surname:"Morari Do Nascimento",slug:"gustavo-morari-do-nascimento",fullName:"Gustavo Morari Do Nascimento"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9888",title:"Nuclear Power Plants",subtitle:"The Processes from the Cradle to the Grave",isOpenForSubmission:!1,hash:"c2c8773e586f62155ab8221ebb72a849",slug:"nuclear-power-plants-the-processes-from-the-cradle-to-the-grave",bookSignature:"Nasser Awwad",coverURL:"https://cdn.intechopen.com/books/images_new/9888.jpg",editedByType:"Edited by",editors:[{id:"145209",title:"Prof.",name:"Nasser",middleName:"S",surname:"Awwad",slug:"nasser-awwad",fullName:"Nasser Awwad"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8098",title:"Resources of Water",subtitle:null,isOpenForSubmission:!1,hash:"d251652996624d932ef7b8ed62cf7cfc",slug:"resources-of-water",bookSignature:"Prathna Thanjavur Chandrasekaran, Muhammad Salik Javaid, Aftab Sadiq",coverURL:"https://cdn.intechopen.com/books/images_new/8098.jpg",editedByType:"Edited by",editors:[{id:"167917",title:"Dr.",name:"Prathna",middleName:null,surname:"Thanjavur Chandrasekaran",slug:"prathna-thanjavur-chandrasekaran",fullName:"Prathna Thanjavur Chandrasekaran"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9644",title:"Glaciers and the Polar Environment",subtitle:null,isOpenForSubmission:!1,hash:"e8cfdc161794e3753ced54e6ff30873b",slug:"glaciers-and-the-polar-environment",bookSignature:"Masaki Kanao, Danilo Godone and Niccolò Dematteis",coverURL:"https://cdn.intechopen.com/books/images_new/9644.jpg",editedByType:"Edited by",editors:[{id:"51959",title:"Dr.",name:"Masaki",middleName:null,surname:"Kanao",slug:"masaki-kanao",fullName:"Masaki Kanao"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10432",title:"Casting Processes and Modelling of Metallic Materials",subtitle:null,isOpenForSubmission:!1,hash:"2c5c9df938666bf5d1797727db203a6d",slug:"casting-processes-and-modelling-of-metallic-materials",bookSignature:"Zakaria Abdallah and Nada Aldoumani",coverURL:"https://cdn.intechopen.com/books/images_new/10432.jpg",editedByType:"Edited by",editors:[{id:"201670",title:"Dr.",name:"Zak",middleName:null,surname:"Abdallah",slug:"zak-abdallah",fullName:"Zak Abdallah"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9671",title:"Macrophages",subtitle:null,isOpenForSubmission:!1,hash:"03b00fdc5f24b71d1ecdfd75076bfde6",slug:"macrophages",bookSignature:"Hridayesh Prakash",coverURL:"https://cdn.intechopen.com/books/images_new/9671.jpg",editedByType:"Edited by",editors:[{id:"287184",title:"Dr.",name:"Hridayesh",middleName:null,surname:"Prakash",slug:"hridayesh-prakash",fullName:"Hridayesh Prakash"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8415",title:"Extremophilic Microbes and Metabolites",subtitle:"Diversity, Bioprospecting and Biotechnological Applications",isOpenForSubmission:!1,hash:"93e0321bc93b89ff73730157738f8f97",slug:"extremophilic-microbes-and-metabolites-diversity-bioprospecting-and-biotechnological-applications",bookSignature:"Afef Najjari, Ameur Cherif, Haïtham Sghaier and Hadda Imene Ouzari",coverURL:"https://cdn.intechopen.com/books/images_new/8415.jpg",editedByType:"Edited by",editors:[{id:"196823",title:"Dr.",name:"Afef",middleName:null,surname:"Najjari",slug:"afef-najjari",fullName:"Afef Najjari"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9731",title:"Oxidoreductase",subtitle:null,isOpenForSubmission:!1,hash:"852e6f862c85fc3adecdbaf822e64e6e",slug:"oxidoreductase",bookSignature:"Mahmoud Ahmed Mansour",coverURL:"https://cdn.intechopen.com/books/images_new/9731.jpg",editedByType:"Edited by",editors:[{id:"224662",title:"Prof.",name:"Mahmoud Ahmed",middleName:null,surname:"Mansour",slug:"mahmoud-ahmed-mansour",fullName:"Mahmoud Ahmed Mansour"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},subject:{topic:{id:"200",title:"Public Health",slug:"medicine-public-health",parent:{title:"Medicine",slug:"medicine"},numberOfBooks:70,numberOfAuthorsAndEditors:1681,numberOfWosCitations:851,numberOfCrossrefCitations:694,numberOfDimensionsCitations:1736,videoUrl:null,fallbackUrl:null,description:null},booksByTopicFilter:{topicSlug:"medicine-public-health",sort:"-publishedDate",limit:12,offset:0},booksByTopicCollection:[{type:"book",id:"9376",title:"Contemporary Developments and Perspectives in International Health Security",subtitle:"Volume 1",isOpenForSubmission:!1,hash:"b9a00b84cd04aae458fb1d6c65795601",slug:"contemporary-developments-and-perspectives-in-international-health-security-volume-1",bookSignature:"Stanislaw P. Stawicki, Michael S. Firstenberg, Sagar C. Galwankar, Ricardo Izurieta and Thomas Papadimos",coverURL:"https://cdn.intechopen.com/books/images_new/9376.jpg",editedByType:"Edited by",editors:[{id:"181694",title:"Dr.",name:"Stanislaw P.",middleName:null,surname:"Stawicki",slug:"stanislaw-p.-stawicki",fullName:"Stanislaw P. Stawicki"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9047",title:"Nursing",subtitle:"New Perspectives",isOpenForSubmission:!1,hash:"1500bf539d1400c51b941e95f3a1f0f9",slug:"nursing-new-perspectives",bookSignature:"Serpil Çelik Durmuş",coverURL:"https://cdn.intechopen.com/books/images_new/9047.jpg",editedByType:"Edited by",editors:[{id:"189558",title:"Ph.D.",name:"Serpil",middleName:null,surname:"Çelik Durmuş",slug:"serpil-celik-durmus",fullName:"Serpil Çelik Durmuş"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6951",title:"Personalized Medicine, in Relation to Redox State, Diet and Lifestyle",subtitle:null,isOpenForSubmission:!1,hash:"2940f812b4520a28d958f5c23c606f02",slug:"personalized-medicine-in-relation-to-redox-state-diet-and-lifestyle",bookSignature:"Faik Atroshi",coverURL:"https://cdn.intechopen.com/books/images_new/6951.jpg",editedByType:"Edited by",editors:[{id:"65639",title:"Dr.",name:"Faik",middleName:null,surname:"Atroshi",slug:"faik-atroshi",fullName:"Faik Atroshi"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"3",chapterContentType:"chapter",authoredCaption:"Authored by"}},{type:"book",id:"8467",title:"Accident Analysis and Prevention",subtitle:null,isOpenForSubmission:!1,hash:"81f08fa6308d78fe644f8544321511cf",slug:"accident-analysis-and-prevention",bookSignature:"Murat Darçın",coverURL:"https://cdn.intechopen.com/books/images_new/8467.jpg",editedByType:"Edited by",editors:[{id:"196869",title:"Dr.",name:"Murat",middleName:null,surname:"Darçın",slug:"murat-darcin",fullName:"Murat Darçın"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8270",title:"Maternal and Child Health Matters Around the World",subtitle:null,isOpenForSubmission:!1,hash:"970e2fb7930d29a8d805900b86da459f",slug:"maternal-and-child-health-matters-around-the-world",bookSignature:"Masoud Mohammadnezhad and Nafisa Huq",coverURL:"https://cdn.intechopen.com/books/images_new/8270.jpg",editedByType:"Edited by",editors:[{id:"257189",title:"Dr.",name:"Masoud",middleName:null,surname:"Mohammadnezhad",slug:"masoud-mohammadnezhad",fullName:"Masoud Mohammadnezhad"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9138",title:"Public Health in Developing Countries",subtitle:"Challenges and Opportunities",isOpenForSubmission:!1,hash:"28c7e86f71905feb65668941c4f259f4",slug:"public-health-in-developing-countries-challenges-and-opportunities",bookSignature:"Edlyne Eze Anugwom and Niyi Awofeso",coverURL:"https://cdn.intechopen.com/books/images_new/9138.jpg",editedByType:"Edited by",editors:[{id:"293469",title:null,name:"Edlyne Eze",middleName:null,surname:"Anugwom",slug:"edlyne-eze-anugwom",fullName:"Edlyne Eze Anugwom"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8831",title:"Environmental Factors Affecting Human Health",subtitle:null,isOpenForSubmission:!1,hash:"88c049685e3808385ac61471dd7f4fbf",slug:"environmental-factors-affecting-human-health",bookSignature:"Ivan Uher",coverURL:"https://cdn.intechopen.com/books/images_new/8831.jpg",editedByType:"Edited by",editors:[{id:"227237",title:"Prof.",name:"Ivan",middleName:null,surname:"Uher",slug:"ivan-uher",fullName:"Ivan Uher"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9105",title:"Heavy Metal Toxicity in Public Health",subtitle:null,isOpenForSubmission:!1,hash:"a2e4f3c444775950ab18bce58a754777",slug:"heavy-metal-toxicity-in-public-health",bookSignature:"John Kanayochukwu Nduka and Mohamed Nageeb Rashed",coverURL:"https://cdn.intechopen.com/books/images_new/9105.jpg",editedByType:"Edited by",editors:[{id:"107866",title:"Dr.",name:"John Kanayochukwu",middleName:null,surname:"Nduka",slug:"john-kanayochukwu-nduka",fullName:"John Kanayochukwu Nduka"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7620",title:"Safety and Health for Workers",subtitle:"Research and Practical Perspective",isOpenForSubmission:!1,hash:"1233909d682e2cced428e1042fd40ad4",slug:"safety-and-health-for-workers-research-and-practical-perspective",bookSignature:"Bankole Fasanya",coverURL:"https://cdn.intechopen.com/books/images_new/7620.jpg",editedByType:"Edited by",editors:[{id:"214494",title:"Dr.",name:"Bankole",middleName:"Kolawole",surname:"Fasanya",slug:"bankole-fasanya",fullName:"Bankole Fasanya"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8036",title:"Healthcare Access",subtitle:"Regional Overviews",isOpenForSubmission:!1,hash:"84f870b3d688da8dd09779ef7507b850",slug:"healthcare-access-regional-overviews",bookSignature:"Umar Bacha, Urška Rozman and Sonja Šostar Turk",coverURL:"https://cdn.intechopen.com/books/images_new/8036.jpg",editedByType:"Edited by",editors:[{id:"244265",title:"Dr.",name:"Umar",middleName:null,surname:"Bacha",slug:"umar-bacha",fullName:"Umar Bacha"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7856",title:"Nutrition and HIV/AIDS",subtitle:"Implication for Treatment, Prevention and Cure",isOpenForSubmission:!1,hash:"94229224705db9f1cd430a32aa777bef",slug:"nutrition-and-hiv-aids-implication-for-treatment-prevention-and-cure",bookSignature:"Nancy Dumais",coverURL:"https://cdn.intechopen.com/books/images_new/7856.jpg",editedByType:"Edited by",editors:[{id:"40783",title:"Dr.",name:"Nancy",middleName:null,surname:"Dumais",slug:"nancy-dumais",fullName:"Nancy Dumais"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8607",title:"Evaluation of Health Services",subtitle:null,isOpenForSubmission:!1,hash:"dbea1d7a6cd5428a713f35c234f5583b",slug:"evaluation-of-health-services",bookSignature:"Sandeep Reddy and Aida Isabel Tavares",coverURL:"https://cdn.intechopen.com/books/images_new/8607.jpg",editedByType:"Edited by",editors:[{id:"230704",title:"Associate Prof.",name:"Sandeep",middleName:null,surname:"Reddy",slug:"sandeep-reddy",fullName:"Sandeep Reddy"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],booksByTopicTotal:70,mostCitedChapters:[{id:"27687",doi:"10.5772/29869",title:"Heavy Metals and Human Health",slug:"heavy-metals-and-human-health",totalDownloads:18303,totalCrossrefCites:53,totalDimensionsCites:110,book:{slug:"environmental-health-emerging-issues-and-practice",title:"Environmental Health",fullTitle:"Environmental Health - Emerging Issues and Practice"},signatures:"Simone Morais, Fernando Garcia e Costa and Maria de Lourdes Pereira",authors:[{id:"13875",title:"Prof.",name:"Simone",middleName:null,surname:"Morais",slug:"simone-morais",fullName:"Simone Morais"},{id:"79715",title:"Prof.",name:"Maria De Lourdes",middleName:null,surname:"Pereira",slug:"maria-de-lourdes-pereira",fullName:"Maria De Lourdes Pereira"},{id:"87294",title:"Prof.",name:"Fernando",middleName:null,surname:"Garcia E Costa",slug:"fernando-garcia-e-costa",fullName:"Fernando Garcia E Costa"}]},{id:"36935",doi:"10.5772/37886",title:"Gender Differences in Food Choice and Dietary Intake in Modern Western Societies",slug:"gender-differences-in-food-choice-and-dietary-intake-in-modern-western-societies",totalDownloads:17210,totalCrossrefCites:33,totalDimensionsCites:90,book:{slug:"public-health-social-and-behavioral-health",title:"Public Health",fullTitle:"Public Health - Social and Behavioral Health"},signatures:"Claudia Arganini, Anna Saba, Raffaella Comitato, Fabio Virgili and Aida Turrini",authors:[{id:"114665",title:"Dr.",name:"Aida",middleName:null,surname:"Turrini",slug:"aida-turrini",fullName:"Aida Turrini"},{id:"116008",title:"Dr.",name:"Claudia",middleName:null,surname:"Arganini",slug:"claudia-arganini",fullName:"Claudia Arganini"},{id:"116171",title:"MSc.",name:"Anna",middleName:null,surname:"Saba",slug:"anna-saba",fullName:"Anna Saba"},{id:"116173",title:"Dr.",name:"Fabio",middleName:null,surname:"Virgili",slug:"fabio-virgili",fullName:"Fabio Virgili"},{id:"116174",title:"Dr.",name:"Raffaella",middleName:null,surname:"Comitato",slug:"raffaella-comitato",fullName:"Raffaella Comitato"}]},{id:"29979",doi:"10.5772/25344",title:"The Therapeutic Benefits of Essential Oils",slug:"the-therapeutic-benefits-of-essential-oils",totalDownloads:23380,totalCrossrefCites:30,totalDimensionsCites:84,book:{slug:"nutrition-well-being-and-health",title:"Nutrition, Well-Being and Health",fullTitle:"Nutrition, Well-Being and Health"},signatures:"Abdelouaheb Djilani and Amadou Dicko",authors:[{id:"63044",title:"Prof.",name:"Jilani",middleName:null,surname:"AbdelWahab",slug:"jilani-abdelwahab",fullName:"Jilani AbdelWahab"},{id:"116762",title:"Prof.",name:"Amadou",middleName:null,surname:"Dicko",slug:"amadou-dicko",fullName:"Amadou Dicko"}]}],mostDownloadedChaptersLast30Days:[{id:"58916",title:"Factors Affecting the Attitudes of Women toward Family Planning",slug:"factors-affecting-the-attitudes-of-women-toward-family-planning",totalDownloads:5905,totalCrossrefCites:3,totalDimensionsCites:7,book:{slug:"family-planning",title:"Family Planning",fullTitle:"Family Planning"},signatures:"Nazli Sensoy, Yasemin Korkut, Selcuk Akturan, Mehmet Yilmaz,\nCanan Tuz and Bilge Tuncel",authors:[{id:"216377",title:"Prof.",name:"Nazli",middleName:null,surname:"Sensoy",slug:"nazli-sensoy",fullName:"Nazli Sensoy"},{id:"216589",title:"Dr.",name:"Yasemin",middleName:null,surname:"Korkut",slug:"yasemin-korkut",fullName:"Yasemin Korkut"},{id:"216595",title:"Dr.",name:"Selcuk",middleName:null,surname:"Akturan",slug:"selcuk-akturan",fullName:"Selcuk Akturan"},{id:"216596",title:"Dr.",name:"Canan",middleName:null,surname:"Tuz",slug:"canan-tuz",fullName:"Canan Tuz"},{id:"216598",title:"Dr.",name:"Bilge",middleName:null,surname:"Tuncel",slug:"bilge-tuncel",fullName:"Bilge Tuncel"},{id:"216599",title:"Dr.",name:"Mehmet",middleName:null,surname:"Yilmaz",slug:"mehmet-yilmaz",fullName:"Mehmet Yilmaz"}]},{id:"56223",title:"Volunteering in Palliative Care in France: “A Tough Job”; Patient, Family, Caregiver, and Volunteer Perspectives",slug:"volunteering-in-palliative-care-in-france-a-tough-job-patient-family-caregiver-and-volunteer-perspec",totalDownloads:2576,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"highlights-on-several-underestimated-topics-in-palliative-care",title:"Highlights on Several Underestimated Topics in Palliative Care",fullTitle:"Highlights on Several Underestimated Topics in Palliative Care"},signatures:"Yaël Tibi-Lévy and Martine Bungener",authors:[{id:"88839",title:"Dr.",name:"Martine",middleName:null,surname:"Bungener",slug:"martine-bungener",fullName:"Martine Bungener"},{id:"205065",title:"Ph.D.",name:"Yaël",middleName:null,surname:"Tibi-Levy",slug:"yael-tibi-levy",fullName:"Yaël Tibi-Levy"}]},{id:"44569",title:"Health Care Waste Management – Public Health Benefits, and the Need for Effective Environmental Regulatory Surveillance in Federal Republic of Nigeria",slug:"health-care-waste-management-public-health-benefits-and-the-need-for-effective-environmental-regulat",totalDownloads:7415,totalCrossrefCites:4,totalDimensionsCites:12,book:{slug:"current-topics-in-public-health",title:"Current Topics in Public Health",fullTitle:"Current Topics in Public Health"},signatures:"Nkechi Chuks Nwachukwu, Frank Anayo Orji and Ositadinma\nChinyere Ugbogu",authors:[{id:"85404",title:"Dr.",name:"Nkechi Chuks",middleName:null,surname:"Nwachukwu",slug:"nkechi-chuks-nwachukwu",fullName:"Nkechi Chuks Nwachukwu"},{id:"120194",title:"Dr.",name:"Orji",middleName:null,surname:"Frank Anayo",slug:"orji-frank-anayo",fullName:"Orji Frank Anayo"},{id:"161783",title:"Dr.",name:"Ositadinma Chinyere",middleName:null,surname:"Ugbogu",slug:"ositadinma-chinyere-ugbogu",fullName:"Ositadinma Chinyere Ugbogu"}]},{id:"66183",title:"Introductory Chapter: Bio-Psychosocial Model of Health",slug:"introductory-chapter-bio-psychosocial-model-of-health",totalDownloads:1752,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"psychology-of-health-biopsychosocial-approach",title:"Psychology of Health",fullTitle:"Psychology of Health - Biopsychosocial Approach"},signatures:"Simon George Taukeni",authors:[{id:"202046",title:"Dr.",name:"Simon George",middleName:null,surname:"Taukeni",slug:"simon-george-taukeni",fullName:"Simon George Taukeni"}]},{id:"55808",title:"The Role of Legumes in Human Nutrition",slug:"the-role-of-legumes-in-human-nutrition",totalDownloads:3865,totalCrossrefCites:20,totalDimensionsCites:37,book:{slug:"functional-food-improve-health-through-adequate-food",title:"Functional Food",fullTitle:"Functional Food - Improve Health through Adequate Food"},signatures:"Yvonne Maphosa and Victoria A. Jideani",authors:[{id:"201151",title:"Ph.D. Student",name:"Yvonne",middleName:null,surname:"Maphosa",slug:"yvonne-maphosa",fullName:"Yvonne Maphosa"}]},{id:"56224",title:"Diet Quality Indices for Nutrition Assessment: Types and Applications",slug:"diet-quality-indices-for-nutrition-assessment-types-and-applications",totalDownloads:3709,totalCrossrefCites:1,totalDimensionsCites:4,book:{slug:"functional-food-improve-health-through-adequate-food",title:"Functional Food",fullTitle:"Functional Food - Improve Health through Adequate Food"},signatures:"Maria Luisa Poyatos Guerrero and Fernando Pérez-Rodríguez",authors:[{id:"82252",title:"Dr.",name:"Fernando",middleName:null,surname:"Pérez-Rodríguez",slug:"fernando-perez-rodriguez",fullName:"Fernando Pérez-Rodríguez"},{id:"207713",title:"MSc.",name:"Maria Luisa",middleName:null,surname:"Poyatos-Guerrero",slug:"maria-luisa-poyatos-guerrero",fullName:"Maria Luisa Poyatos-Guerrero"}]},{id:"69468",title:"The Global Burden and Perspectives on Non-Communicable Diseases (NCDs) and the Prevention, Data Availability and Systems Approach of NCDs in Low-resource Countries",slug:"the-global-burden-and-perspectives-on-non-communicable-diseases-ncds-and-the-prevention-data-availab",totalDownloads:1626,totalCrossrefCites:0,totalDimensionsCites:2,book:{slug:"public-health-in-developing-countries-challenges-and-opportunities",title:"Public Health in Developing Countries",fullTitle:"Public Health in Developing Countries - Challenges and Opportunities"},signatures:"Melkamu Kassa and Jeanne Grace",authors:[{id:"306689",title:"Dr.",name:"Melkamu",middleName:null,surname:"Kassa",slug:"melkamu-kassa",fullName:"Melkamu Kassa"},{id:"306691",title:"Dr.",name:"Grace",middleName:null,surname:"Jeanne",slug:"grace-jeanne",fullName:"Grace Jeanne"}]},{id:"54225",title:"Patient-Centred Care in Maternity Services",slug:"patient-centred-care-in-maternity-services",totalDownloads:1123,totalCrossrefCites:1,totalDimensionsCites:1,book:{slug:"patient-centered-medicine",title:"Patient Centered Medicine",fullTitle:"Patient Centered Medicine"},signatures:"Claire de Labrusse, Anne Sylvie Ramelet, Tracy Humphrey and Sara\nMacLennan",authors:[{id:"191347",title:"Ph.D. Student",name:"Claire",middleName:null,surname:"De Labrusse",slug:"claire-de-labrusse",fullName:"Claire De Labrusse"},{id:"206437",title:"Prof.",name:"Anne-Sylvie",middleName:null,surname:"Ramelet",slug:"anne-sylvie-ramelet",fullName:"Anne-Sylvie Ramelet"}]},{id:"67470",title:"Healthcare Coverage and Affordability in Nigeria: An Alternative Model to Equitable Healthcare Delivery",slug:"healthcare-coverage-and-affordability-in-nigeria-an-alternative-model-to-equitable-healthcare-delive",totalDownloads:1362,totalCrossrefCites:1,totalDimensionsCites:3,book:{slug:"universal-health-coverage",title:"Universal Health Coverage",fullTitle:"Universal Health Coverage"},signatures:"Alex E. Asakitikpi",authors:[{id:"290324",title:"Associate Prof.",name:"Alex",middleName:null,surname:"Asakitikpi",slug:"alex-asakitikpi",fullName:"Alex Asakitikpi"}]},{id:"58297",title:"Family Planning Services in Africa: The Successes and Challenges",slug:"family-planning-services-in-africa-the-successes-and-challenges",totalDownloads:1190,totalCrossrefCites:3,totalDimensionsCites:5,book:{slug:"family-planning",title:"Family Planning",fullTitle:"Family Planning"},signatures:"Alhaji A Aliyu",authors:[{id:"217688",title:"Prof.",name:"Alhaji A",middleName:null,surname:"Aliyu",slug:"alhaji-a-aliyu",fullName:"Alhaji A Aliyu"}]}],onlineFirstChaptersFilter:{topicSlug:"medicine-public-health",limit:3,offset:0},onlineFirstChaptersCollection:[],onlineFirstChaptersTotal:0},preDownload:{success:null,errors:{}},aboutIntechopen:{},privacyPolicy:{},peerReviewing:{},howOpenAccessPublishingWithIntechopenWorks:{},sponsorshipBooks:{sponsorshipBooks:[{type:"book",id:"10176",title:"Microgrids and Local Energy Systems",subtitle:null,isOpenForSubmission:!0,hash:"c32b4a5351a88f263074b0d0ca813a9c",slug:null,bookSignature:"Prof. Nick Jenkins",coverURL:"https://cdn.intechopen.com/books/images_new/10176.jpg",editedByType:null,editors:[{id:"55219",title:"Prof.",name:"Nick",middleName:null,surname:"Jenkins",slug:"nick-jenkins",fullName:"Nick Jenkins"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],offset:8,limit:8,total:1},route:{name:"profile.detail",path:"/profiles/159668/kiril-tenekedjiev",hash:"",query:{},params:{id:"159668",slug:"kiril-tenekedjiev"},fullPath:"/profiles/159668/kiril-tenekedjiev",meta:{},from:{name:null,path:"/",hash:"",query:{},params:{},fullPath:"/",meta:{}}}},function(){var e;(e=document.currentScript||document.scripts[document.scripts.length-1]).parentNode.removeChild(e)}()